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Abstract 
 
 
Methamphetamine (METH) is a highly addictive drug of abuse that has a severe 
impact on neuronal changes in the brain including modulations of plasticity, cognitive 
dysfunction, as well as memory impairment. These changes can be seen as modifications 
in the expression of biochemical markers associated with synaptic plasticity. One such 
marker associated with memory impairment is alpha synuclein (α-syn). Alteration of α-
syn expression has been linked to memory impairment in patients with Alzheimer’s 
disease (AD) and Parkinson’s disease (PD). Here we assess the effect of chronic METH 
treatment in correlation to cognitive functions.  
  Twenty-nine guinea pigs (male, 150-250 g) were subcutaneously inserted with 
ALZET osmotic mini-pumps to deliver either a) saline (24 μl/day), b) METH (10 mg/kg) 
per day  for 7 days or c) Post  METH washout (10mg/kg) . On Day–7, the Novel Object 
Recognition test (NOR) was used to assess memory recall. Electrophysiological 
techniques were used to assess synaptic plasticity, in the hippocampus CA1 subfield, as it 
relates to learning and memory (n=6). Western blots were used to evaluate the expression 
of α-syn in the hippocampus. 
 Saline treated animals (n=7) and the Post METH washout (n=12) showed a 
preference for the novel object as compared to the METH treated animals (n=10) that had 
a preference for the familiar object.even after 7 days post treatment (n=12). Molecular 
assays showed a down regulation of endogenous alpha synuclein protein levels in the 
hippocampus between subgroups. Furthermore, long-term potentiation (a cellular 
correlate of memory) was maintained in all subgroups. 
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The results from this study warrant the conclusion, that METH affects some of the 
same mechanisms underlining memory function and the drug-induced activation lead to 
the memory impairments observed in METH addicts and the role of alpha synuclein in 
the memory function still remains unclear. 
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Literature review 
 
 
1.1 Methamphetamine 
 
The abuse of Methamphetamine (METH) in the United States has increased 
markedly in the past 15 years (Cretzmeyer et al., 2003; Rawson et al., 2002; Marshall et 
al., 2007). Due to its inexpensive production and low cost, METH is the most synthesized 
illegal drug in the USA with an increasing pattern of use in pre-teens and adolescents 
(Cretzmeyer et al., 2003) See Figure 1 for molecular structure of METH. Second to 
Cannibas, METH is the most popular drug of recreational use in the United States. It is a 
synthetic derivative of amphetamine, highly addictive, and chronic use has been linked to 
several neurocognitive impairments (Ares-Santos, et al., 2011).   
 METH can enter the central nervous system (CNS) passively or through the 
dopamine transporters (DAT) and acts on the CNS through a non-exocytotic mechanism, 
causing the release of monoamine neurotransmitters such as dopamine, norepinephrine 
and serotonin (Makisumi et al., 1998). METH has the ability to (i) redistribute 
catecholamines from the synaptic vesicles to the cytosol, (ii) reverse the transport of the 
neurotransmitters through plasma membrane transporters (Khoshbouei et al., 2003), and 
(iii) inhibit the activity of monoamine oxidase (MAO), an enzyme that degrades amine 
neurotransmitters such as dopamine, serotonin, and norepinephrine (Barr et al., 2006; 
Mantle et al., 1976).  
Typically, individuals who chronically abuse METH display signs of acute 
toxicity,  neurological damage, hypertension, aggression, impaired judgments, seizures, 
anxiety, depression and altered behavior and cognitive function (Albertson et al., 1999; 
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Barr et al., 2006; Murray 1998). Neuroimages of METH abusers show many 
morphological changes that occur with sustained usage. These changes include persistent 
decreases in the levels of dopamine transporters (DAT) in the orbitofrontal cortex, 
dorsolateral prefrontal cortex, and the caudate-putamen (Iyo et al., 2004; McCann et al., 
1998; Sekine et al., 2003; Volkow et al., 2001),  and a decrease in the density of 
serotonin transporters (5-HTT) in the midbrain, caudate-putamen, hypothalamus, 
thalamus, and the orbitofrontal, temporal, and cingulate cortices (Sekine et al., 2006; 
Aron and Paulus, 2007; Chang et al., 2007). As demonstrated by Thompson et al., 
(2008), METH exposure can result in extensive neuronal damages that can be seen 
distinctly in neuro imaging techniques in animals in vivo. For example, magnetic 
resonance imaging (MRI) has shown morphological changes in the brain that consist of a 
loss of gray matter in the cingulate, limbic and paralimbic cortices, along with significant 
shrinkage of the hippocampi and hypertrophy of white matter  
METH has relatively high lipid solubility, allowing for more rapid transfer of the 
drug across the blood–brain barrier especially in the hippocampus (Martins et al., 2011). 
The increase of the drug in the brain can compromise the permeability of the blood brain 
barrier in the hippocampus within 24 hours after injection in young adult mice (Martins et 
al., 2011). The lipophilic ability of METH is likely attributed to its 10-12 hour plasma 
half-life in humans (Schepers et al., 2003; Martins et al., 2011). Furthermore, repeated 
exposure of moderate-to-high doses of METH produces blood-brain barrier disturbances  
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Methamphetamine Structure 
 
 
 
Figure1. The structure of METH. Adapted from  
http://www.sigmaaldrich.com/catalog/product/sigma/m8750 
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that induce neuronal damages, myelin degeneration, reactive astrocytosis in the parietal 
and occipital cortices of the brain (Sharma et al., 2009) and long-term damage to 
presynaptic dopaminergic and serotonergic terminals (Wagner et al., 1980; Ricaurte et 
al., 1982;Wilson et al., 2003; McCann et al., 1998).   
While the cellular and neurochemical repercussions of various METH dosing 
regimens have been investigated extensively, less is known concerning the cognitive 
function of humans and animals following chronic METH administrations. 
Neuropsychological studies have detected deficits in attention, working memory, and 
decision making with active METH use (Gonzalez et al., 2007; Verdejo-Garcia et al., 
2006; Woods et al., 2005). Additionally, withdrawal from METH can produce irritability, 
fatigue, impaired social functioning, and intense craving for the drug (Brecht et al., 2004; 
Darke et al., 2008; Homer et al., 2008; Sekine et al., 2006; Zweben  et al., 2004). Even 
after 3 months of abstinence, recovering METH abusers score worse on word recognition 
and tests of episodic memory than individuals who do not use METH (Simon et al., 
2004).  
Drugs of abuse such as METH can utilize synaptic circuits in the 
mesolimbic/mesocortical or the nigrostriatal pathway to induce abnormal drug reward 
systems and extreme addictions (Kalivas and Volkow, 2005; Jones & Bonci, 2005, 
Hyman et al. 2006) as indicated in Figure 2.  The mesolimbic dopamine pathway 
contains neurons that originate in the A10 region of the ventral tegmental area (VTA) of 
the midbrain and project to the nucleus accumbens and other structures of the basal 
forbrain, including the hippocampus and the caudate-putamen (Bjorklund and Lindvall, 
1975). Wise and Bozarth postulated that psychostimulants use the 
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mesolimbic/mesocortical pathways to produce euphoric effects in humans (1985).  The 
nigrostriatal dopamine pathway originates in the substantia nigra pars compacta and 
projects into the striatum (Bjorklund and Lindvall, 1975). The nigrostriatal pathway plays 
a primary role in movement initiation and control. The functional significance of this 
pathway is best illustrated in Parkinsons disease (PD) that results in rigidity, bradykinesia 
and some form of memory loss (Bannon et al., 2005). 
Taken together, METH use is shown to be associated with neurocognitive 
impairments that include poor performance on measures of attention/information 
processing speed, learning and memory, and frontal lobe functioning (Kalechstein and 
Newton 2003; Quinton and Yamamoto 2006).  Memory tasks are the most pronounced 
deficits in METH users. These memory deficits have been demonstrated on tests of 
verbal (Hoffman et al., 2006), working (Gonzalez et al., 2007), prospective (Rendell et 
al., 2009), and episodic memory (Simon et al., 2004).  Even after METH use has stopped, 
40% of the individuals still experience neurocognitive impairments (Cherner et al., 
2010). Clinically, current and abstinent METH users show impairments in tests of verbal 
memory, manipulation of information, and motor performance (Volkow et al., 2001; 
Simon et al., 2002; Thompson et al., 2004). These observations further support the 
hypothesis that METH has an effect on learning and memory. 
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Synaptic Pathways 
  
  
Figure 2. Modified diagram of the mesolimbic/nigrostriatal pathways. METH can use 
these pathways to induce neuronal damage to the limbic system. Adapted from  
www.elsevierimages.com/image/33387. 
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1.2 The Hippocampus 
 
 
 As part of the limbic system, the hippocampus is located on the medial surface of 
the temporal lobe and has major functions in learning and memory ( Kuno, 1995). The 
hippocampus is divided into four sections that include the dentate gyrus, the 
hippocampus proper, the subiculum, and the entorhinal cortex. Within the different 
sections of the hippocampus, there are several molecular layers that include (1) an 
external plexiform layer, which consist of axons of pyramidal cells that project outside 
the hippocampus and hippocampal afferent fibers from the entorhinal cortex; (2) stratum 
oriens with basal dendrite and basket cells (3), a pyramidal cell layer that contains the 
pyramidal cells of the hippocampus, and (4) the stratum radiatum and stratum lacunosum 
moleculare (Arbib et al., 1998). 
 The entorhinal cortex (EC) is the major source of projections into the hippocampus 
via the perforant pathway. Two-thirds of the cortical input to the entorhinal cortex 
originates in the perirhinal and parahippocampal cortices, which in turn receive 
projections from areas in the frontal temporal, and parietal lobes of the brain (Squire and 
Zora-Morgan, 1991) As seen in Figure 3, the EC projects to the dentate gyrus (DG) and 
the CA3 through the perforant path (pp) (Witter et al., 1988, 2007).  In turn, the dentate 
gyrus (DG) projects to the CA3 through the mossy fibers (mf). The CA3 projects to the 
CA1 through the Schaffer Collateral (SC) and the CA1 projects outside the hippocampus 
back to the of the entorhinal cortex in a loop. Also, the CA1 can receive direct 
information from the EC and the CA3.  
  The hippocampus and adjacent structures in the medial temporal lobe memory 
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system function as storage for simple memory (Marr, 1971).  The hippocampus is crucial 
for rapid acquisition of new information about facts and events, which is available as 
conscious recollection (Squire and Zola, 1996).   
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Structure of the Hippocampus 
 
 
 
 
 
Figure 3.  The structure of the hippocampus. The EC projects to the dentate gyrus (DG) 
and the CA3 through the Perforant Path.  In turn, the DG projects to the CA3 through the 
mossy fiber (mf) which projects to the CA1 through the Schaffer Collateral (sc). The 
CA1 projects back to the EC. Adapted from en.wikipedia.org 
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1.3  Memory  
 
Studies of memory have led to a consensus that memory is not a monolithic, but 
rather is supported by multiple brain systems that differ in terms of the types of memory 
they mediate. The Multiple Memory Systems Theory states that there are specific circuits 
that serve specific classes of learning and memory problems (Squire and Zola-Morgan, 
1991). This theory was originally derived largely in part from patterns of impaired and 
spared learning abilities following damages to the mammalian hippocampal system 
(Cohen and Squire, 1980; Hirsh, 1974; Saunders et al., 1984; Squire, 1992).  
 According to McGaugh et al. (2000), there are three main memory systems: 
working memory, short-term memory, and long-term memory. See Figure 4 for a 
schematic of different memory groups. Working memory system occurs immediately 
while an event is presently occurring and only last for a few seconds to a few minutes 
(McGaugh et al., 1966; Izquerido et al., 1999; Gold et al., 1975; Goldman-Rakic et al., 
1992). The  Izquerido et al. (1999), study demonstrate that working memory does not 
retain an archive of memories, but rather moment to moment events that may or may not 
relate to events already stored in the brain. Working memory serves simultaneous 
information, storage, and processing functions (Baddeley, 2000). Working memory 
impairments are commonly found in older adults who often have difficulty performing 
dual tasks that require both storage and processing (Salthouse, 1996);  
 Short-term memory, on the other hand, is the ability to acquire new information and 
retain it for periods of time ranging from a few seconds or a few minutes and lasts for 
several hours (Tulving et al., 1997; Gold et al., 1975). Short term memory requires  
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Memory Systems 
 
 
 
 
 
 Figure 4. Types of human memories. Adapted from http://www.human-memory.net. 
 
 
 
 
 
 
 
 
Human Memory 
Long Term Memory 
(LTM) 
lifetime 
Implicit Memory 
(Unconscious) 
Procedural Memory 
(facts and events) 
Explicit Memory 
(Conscious ) 
Declarative Memory 
(facts and 
experience) 
Semantic Memory 
(facts, concepts) 
Episodic Memory 
(events and 
experience) 
Short Term Memory 
(STM) 
few hours 
Working Memory 
(WM) 
(< 1 min) 
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rehearsal or repetition of the information and sorting or categorization of that information 
into systematic chunks. The sorting process is usually called coding or chunking (Gold et 
al., 1975).  Short-term memory is thought to be translated into long-term memory via 
permanent modification of proteins or by the synthesis of new proteins (Costa-Mattioli, 
2008; Moncada and Viola, 2007). Long-term memory involves the retention of new 
information and lasts from hours to even a lifetime (Levitian and Kaczmarek, 1991). 
Long-term memory can further be divided into declarative and non-declarative 
memory (Levitian and Kaczmarek, 1991). Declarative memory refers to the capacity to 
consciously remember the past and depends on the integrity of the medial temporal lobe 
structures (Squire and Clark, 2007). Declarative memory or explicit memory is the 
conscious recollection of specific facts and events (Squire and Zola-Morgan 1996). 
Explicit memory, a subgroup of declarative memory, is explicitly located in the past and 
is accompanied by the feeling of remembering when subjects can retrieve the correct item 
(Ennaceur, 2010). This type of long-term memory encourages recognition memory. In 
preclinical rodent models, components of episodic memory can be evaluated by an object 
recognition task to assess recognition memory (Ennaceur, 2010). Non-declarative 
memory or implicit memory is the non-concsious learning capacities that include 
memory for skills and procedures (Squire and Zola-Morgan 1996). Non-declarative 
memories are procedural skills that are learned through practice such as riding a bike 
(Willingham, 1998). It is often slow, learned in segments, and requires immediate and 
constant feedback along with repetition ( Willingham, 1998). Consolidation of long-term 
memory is slow, passive, and relatively permanent (Wolfman et al., 1994).A neuronal 
13 
 
mechanism to assess learning and memory is synaptic plasticity. It is a process that is 
actively occurring as memory moves from short term to long term memory.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
1.4  Synaptic Plasticity  
 
Learning and memory require persistent changes in neuronal circuits (Nestler et 
al., 2004). These changes, according to the Hebbian theory, occur when the connections 
between coactive cells change and thereby store a record of the event (Cooper, 2005). 
This is due to the increase in synaptic efficiency that arises from the cell’s repeated and 
persistent stimulation of the post synaptic cell to induce what is known as synaptic 
plasticity.  According to Hebb, if the presynaptic and the postsynaptic elements are 
coactive and calcium influx is sufficient, then the strength of the synapse increases 
(Cooper, 2005). The ability of the brain to adapt and respond to changes in the 
environment is referred to as neuroplasticity (Nestler et al., 2004). This plasticity is 
important for learning and memory as it is the underlying mechanism for memory 
formation (Nestler et al., 2004; Jones & Bonci, 2005). Thus, learning and memory 
require neuronal mechanisms that allow rapid, persistent changes to brain circuits to 
account for plasticity (Shapiro, 2001). The circuits that are located within the 
hippocampus are remarkably plastic, and this plasticity is mediated in part through 
changes in synaptic strength.. 
Synaptic plasticity can be defined by two parameters: (1) the amount of 
transmitter released from the presynaptic terminals and (2) the size of the postsynaptic 
response produced per unit amount of transmitter (Kandel, 2009).  Plasticity occurs when 
there are changes in one or both of the parameters. It can be divided into short–term 
(minutes to hours) and long-term (days to years) (Kandel and Schwartz, 1982). Long-
term synaptic plasticity is a form of plasticity that is relevant in the efficiency of learning 
15 
 
and memory in the brain because it also requires changes in synaptic structures and gene 
expression (Malenka and Bear, 2004; Kandel, 2009). The most well-known and studied 
mechanism of neural plasticity is long-term potentiation (LTP) or long-term depression 
(LTD) as these long-lasting synaptic changes are widely believed to be the cause of many 
forms of long lasting memory changes ( Bliss and Lomo, 1973;  Kandel, 2009) 
LTP is defined as an activity-dependent enhancement of synaptic strength and is 
the general cellular model of learning-induced plasticity in the hippocampus (Bliss et al., 
1973; Clarke et al., 2010). The term LTP was coined by Bliss and Lomo in 1973, in an 
experiment when a brief tetanic stimulation (10-100 hertz for 3-20 sec) was applied to the 
perforant path presynaptic fibers in the dentate gyrus of a rabbit. The postsynaptic 
response was recorded from the granular cells of the hippocampal formation and lasted 
for more than 3 days (Bliss and Lomo 1973).  The results suggested that two independent 
mechanisms were responsible for LTP: an increase in the efficiency of synaptic 
transmission at the perforant path synapses and an increase in the excitability of the 
granule cell population (Bliss and Lomo, 1973). 
  Classic LTP has been characterized by two phases, (1) early-LTP that is initiated 
in the absence of protein synthesis (1-2 hrs) and (2) a late-LTP that requires the synthesis 
of new proteins and lasts longer than 3 hours (Huang and Kandel ., 1998).  Early-LTP is 
typically initiated with a single train of high-frequency stimuli (100 Hz, 1 sec) and starts 
immediately after post-tetanic stimulation (Huang and Kandel., 1998; Kandel, 2009). 
Once early-LTP is initiated, it is maintained by the activation of NMDA receptors which 
leads to the influx of calcium and leads to the activation of secondary messengers 
(Malenka et al., 1988; O’Dell and Kandel et al., 1991).  It has been suggested that early-
16 
 
LTP may involve temporary modifications of existing protein (Malenka et al., 1988; 
Huang and Kandel 1998,).  Late-LTP is typically initiated with three trains of high-
frequency stimuli (100 Hz, 1 sec, at 60 sec intervals) and typically starts three hours after 
post-tetanic stimulation (O’Dell and Kandel et al., 1991; Pittenger et al., 2006). Late-LTP 
also requires the activation of the N-Methyl-D-aspartate (NMDA) receptors, voltage 
dependent calcium channels, and may require protein synthesis (Raymond, 2007; Nguyen 
et al.; 2003).   
LTP can also be measured by changes in plasticity as represented by ongoing 
molecular events in the cell. The major excitatory transmitter substance in plasticity is 
NMDA (Kuno, 1995). According to Shapiro NMDA receptors are crucial for inducing 
these plastic changes, and blocking these receptors reduces plasticity and impairs learning 
in tasks that require the hippocampus (2001). Modifications, such as the introduction of a 
drug or a NMDA antagonist can disrupt signaling mechanisms downstream of the 
NMDA receptor, leading to the prevention of LTP induction and to the impairment of 
hippocampus-dependent learning (Kuno, 1995). 
  In the hippocampus, NMDA receptors are commonly implicated in activating 
nuclear gene transcription (Worley et al., 1993; Ghosh and Greenberg, 1995; Finkbeiner 
and Greenberg, 1998). As indicated in Figure 5, once NMDA receptors are activated by 
neurotransmitters, a signal is generated to secondary messengers to activate also. The 
increase in second-messenger levels that occurs activates different protein kinases, such 
as protein kinase A (Shaywitz and Greenberg, 1999) and calcium- and calmodulin-
dependent kinase IV (Ginty 1997; Shaywitz and Greenberg, 1999; Wu et al., 2001). The  
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Summary of Transcriptional Regulation by Neurotransmitters 
 
 
 
 
 
 
 
 
 
Figure 5. Summary of the overall biochemical cascade by which ligands such as METH 
can alter gene transcription in the nervous system.  Adapted from: 
www.chemistry.emory.edu 
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nuclear targets for the activated kinases include many things, such as regulatory 
transcription factors (RTFs) like the cAMP response element binding protein 
(CREB).CREB binds to a cAMP response element (CRE) in many gene promoters 
including growth factors, enzymes, other transcription factors, and structural proteins 
(Ginty 1997; Lonze and Ginty, 2002). CREB can also be modified in various ways that 
can lead to changes in its activity or stability (Johannessen et al., 2004). When CREB 
binds to CRE it becomes “active” due to the phosphorylation that occurs at Ser-133 
(Ginty, 1997).  Studies have shown that late-phase LTP at the cortical synapses lead to 
the increase of Ser-133 phosphorylation of CREB and this increases the CREB activity in 
the hippocampus (Johannessen et al., 2004; Shaywitz and Greenberg, 1999)). This 
prolonged Ser-133 phosporylation of CREB is observed when it is activated by upstream 
modulators of extracellular signal-regulated kinases (ERK) and may play a role in the 
maintenance of LTP and normal memory (Wu et al., 2001).  
Additionally, CREB activity is increased in reward-related areas of the brain 
following chronic or acute treatment with psychostimulates such as amphetamine and 
cocaine (Konradi et al., 1994; Hyman et al., 1996;). The increases in CREB activity 
following chronic drug use suggest involvement in the reward-related drug addictions 
and the modification of gene expression (Nestler, 2004). 
We have reviewed that chronic drug use has severe impacts on memory 
formation, reactivation, and reconsolidation suggesting that neuronal changes are 
occurring within the brain (Huang and Kandel, 1998). These changes in long lasting 
neuronal plasticity have been the accepted model to study memory formation.  
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1.5 Alpha Synuclein 
 
The synucleins are small soluble presynaptic proteins expressed primarily in the 
neural tissue (George, 2002). The synuclein family consists of three distinct proteins that 
have been described only in vertebrates (Spillantini et al., 1995). The alpha and beta 
synuclein proteins are found in abundance primarily in the brain tissue while the gamma 
protein is found primarily in the peripheral nervous system and retina (George, 2002). 
The first synuclein was identified from a purified cholinergic vesicle from the electric 
organ of the Pacific electric ray Torpedo californica where it was found in both the nerve 
terminals and the nuclear envelope (Maroteaux et al., 1988).  
 Alpha–synuclein (α-syn) is a small protein of 140 amino acids, 17 kda, that is 
localized in the cytosol of the presynaptic terminal of neuronal tissues. α -syn is 
predominately expressed in the hippocampus, neocortex, thalamus, and the substania 
nigra (Yoshimoto et al., 1995; Murphy et al. 2000; Barr et al., 2006; Schultz-Schaeffer, 
2010). It belongs to a family of loosely folded proteins (Weinreb et al., 1996; Uversky et 
al., 2001). Although cellular functions have not been determined for any of the synuclein 
proteins, but mutations in the α-syn gene have been implicated in many 
neurodegenerative diseases such as Alzheimer’s and Parkinson disease through abnormal 
accumulation, gene triplication, or misfolding (Polymeropoulous et al., 1997).  
Researchers have suggested α-syn may play a role in modulating numerous 
cellular functions. These roles include (1) modulating vesicular synaptic release (Murphy 
et al., 2000),  (2) cell signaling,  (Kurz et al., 2010), (3) neuronal plasticity (Clayton and 
George, 1998),  (4) synaptic function maintenance ( Petersen  et al., 1999), (5) regulation 
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of distinct pools of synaptic vesicles in mature neurons (Murphy et al., 2000), (6) 
inhabitation of phospholipase D activity which is linked to pathways of cell growth, 
neurotransmitter release and differentiation (Jenco et al., 1998;),  (7) defensive role in 
response to neuronal cell injury (Kholodilov et al., 1999), functions in oxidative stress 
(Lee et al., 2006;), and (8) synaptic release by promoting SNARE complex assembly 
(Perez et al., 2002) 
One study has suggested that under normal physiological conditions, α-syn exists 
in an α-helix rich tetramer that is not prone to aggregation (Bartels et al., 2011). However 
under disease conditions, the protein may misfold into β-sheet-rich conformations and 
aggregate into fibrils which are the main components of Lewy bodies and Lewy neurites. 
A classical Lewy body is an eosinophilic cytoplasmic inclusion that consists of a dense 
core surrounded by a halo of 10 nm-wide radiating fibrils, the primary structural 
component of which is α-syn (Bartels et al., 2011; Spillantini et al., 1998;).   Under 
abnormal physiological conditions, disruption of the local alpha helical structure can 
occur and the β-pleated sheets can be extended to render mutant α-syn that is more prone 
to self aggregation and abnormal deposition in the brain (Kruger et al., 1998; 
Polymeropoulous et al., 1997).   
Alpha-syn is often associated with neurodegenerative diseases associated with 
cognitive declines such as Alzheimer disease (AD) and Parkinson’s disease (PD) (Norris 
et al., 2004). Other studies have shown that an over expression of α-syn or a missense 
mutation on the gene can lead to rare forms of PD (Polymeropoulos et al., 1997; 
Spillantini et al., 1998). In the familial form of PD, there is a missense in the α-syn gene, 
Ala53Thr (Polymeropoulous et al., 1997) or Ala30Pro (Kruger et al., 1998). PD is 
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clinically classified as a movement disorder characterized by tremor, rigidity, 
bradykinesia, and a progressive loss of dopaminergic neurons from the substania nigra 
containing Lewy bodies and Lewy neuritis surrounded by a halo constructed by α-syn 
(Forno et al., 1996). Filamentous α-syn has been shown to be the major component of 
these deposits that have been seen in the identification of mutations in the early onset of 
familial PD (Spillantini et al., 1998; Polymeropoulous et al., 1997). A study by Kirik et 
al., suggested that Parkinson-like degeneration is induced by a targeted over expression 
of α-syn using viral vectors in the nigrostriatal system in mice (2003).   
Although the ability of α-syn to form fibrils has been demonstrated in numerous 
in vitro studies, the molecular mechanism of this process remains unclear. One possible 
mechanism in the formation of α-syn fibril involves a c-terminally truncated α-syn 
(Crowther et al., 1998). These truncated forms of α-syn (1-131, 1-120, 1-81) are able to 
assemble into filaments similar to those found in neurodegenerative diseases (Crowther et 
al., 1998; Uversky et al., 2001). Another mechanism points to the absence of significant 
secondary structure and the lack of hydrophobic core of α-syn, as viewed by UV 
spectroscopy (Kim, 1997; Weinreb et al., 1996), may lead to α-syn transformation from 
the normal soluble form of the monomeric protein into an insoluble conformation 
(Uversky et al., 1998). This is a critical step before fibril formation which is initiated by 
nucleation, followed by oligomerization, and leads to profibrils and finally fibrillization 
(Uversky et al., 1998).  Recent studies have revealed that the accumulation of α-syn can 
result in immediate formation of different sizes and shapes of oligomers (Conway et al., 
2000; Tsigenly et al., 2008;). These oligomers interact with lipids, disrupt membranes, 
and cause cell death in vitro in non-mammalian models (Conway et al., 2000).  These α-
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syn oligomers increase intracellular calcium levels, decrease cAMP response element-
binding protein (CREB) transcriptional activity, and have a detrimental impact on 
neuronal welfare and memory functions in cultures neuroblastoma cells of the 
hippocampus  (Martin et al., 2011). According to Martin et al., (2011) CREB inhibition 
and calcineurin induction were observed when α-syn oligomers were applied to brain 
slices. This interfered with hippocampal long-term potentiation and impaired memory 
through a calcineurin-dependent mechanism (2011).  In fact, oligomer toxicity is 
exemplified in some forms of PD such as the juvenile form in the absence of Lewy body 
formation (Olanow et al., 2004).  
A recent study has suggested that fragments of α-syn can associate with amyloid 
plaques and promote the aggregation of α-syn in the limbic regions of Alzheimer’s 
patients in vivo (Crews et al., 2009). Furthermore, it is speculated that α-syn olgimer 
accumulation specifically damages limbic structures that are associated with the 
neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease and 
may cause memory deficits (Hashimoto et al. 2003; Braak and Braak 1999;). However a 
study by Lim et al., 2011, suggests the suppression of α-syn can cause the reversal of 
synaptic and memory defects in mouse models with dementia and lewy bodies (Lim et 
al., 2011). This may suggest that α-syn is likely to play a role in memory formation and 
plasticity (George et al. 2002; Lim et al., 2011) For this study, a novel object recognition 
(NOR) behavioral task, electrophysiology and methamphetamine as a pharmacological 
agent will be used to investigate the effects of α-syn on memory consolidation. 
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Alpha synuclein Fibrils 
 
 
 
Figure 6: Electron micrograph of in vitro assembled α-syn fibrils. Taken from 
http://www2.mrc-lmb.cam.ac.uk/archive/papers/CP72-12.pdf  
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Specific Aims 
 
 
The aim of this study was to determine if chronic METH administration causes molecular 
and behavioral modification associated with α-syn expression. Since α-syn accumulation 
has been implicated in memory impairment, we addressed the following: 
 
(1) To access the effect of chronic METH on memory consolidation and synaptic 
plasticity by using novel object recognition test (NOR) and Electrophysiology as 
assessment tools, and  
 
(2) Evaluate if METH alters α-syn expression in the hippocampus  
 
It is hypothesized that chronic METH interferes with memory formation partly as a 
consequence of drug-induced alterations in α-syn expression. 
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2. Materials and Methods 
2.1 Animals 
 Twenty-nine male Hartley (HA) guinea pigs (2 weeks old; 200-250 g) were 
obtained from Charles Rivers Laboratory (Wilmington, MA).  The animals were housed 
in groups of two per cage (18.5 x 18.5) at the Animal Care Facility (ACF) Center at 
Meharry Medical College (Nashville, TN). They were kept in a 12:12 hr light/dark cycle 
for at least 3 days prior to any drug treatment or experimental procedures. The ACF 
maintained the animals in temperature controlled rooms at 65-70 °F. The animals were 
housed for a maximum of 21 days total. The animals had access to food and water ad 
libitum. A maintenance record of each guinea pig was kept indicating date of arrival, 
weight, age, date used, and treatment regimen. Animals were processed in accordance 
with guidelines and regulations of the Institutional Animal and Care and Use Committee 
(IACUC) for the use of vertebrate animals. 
 
2.2 Pharmacology 
      METH, obtained from Sigma (CAS # 51-57-0;  St. Louis, MO), was administered to 
guinea pigs to determine its effect on recognition memory, synaptic plasticity and 
expression of α –synin the hippocampus. Each guinea pig was weighed prior to surgery to 
calculate the appropriate amount of METH dosage to ensure that 10 mg/kg would be 
received throughout a 24 hour period through the azlet mini pump (Durect Corporation; 
Cupertino, CA). METH was dissolved in Phosphate Buffer Saline (PBS).  
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2.3 Surgery 
Guinea pigs (n=29) were anesthetized with (4%) isofluorane as general 
anesthesia. Alzet mini-pumps (Durect Corporation; Cupertino, CA) were implanted 
subcutaneously on the back of the guinea pigs and were set to deliver a continuous 
infusion of METH ( 10 mg/kg; Sigma; St. Louis, MO) or saline (0.9% NaCl solution for 
7 or 14 days. The incisions made in the skin were sutured closed with surgical staples and 
the guinea pigs were allowed to recover from the local anesthesia.  
 
 
2.4 Treatments 
       The basic treatment designs in the studies are in Figures 7 – 9. All guinea pigs were 
used in Novel Object Recognition (NOR) (n=29) task after the appropriate treatment was 
given. Guinea pigs were randomly assigned to electrophysiology (n=6), molecular 
analysis (n=14), and the remaining animals were used for other studies. For the molecular 
analysis, guinea pigs were assigned to one of three experimental groups that were 
identified as (a) 7 day METH treatment, (i.e. 10 mg/kg/day; n=6), (b) Post Washout 
group, (i.e. 10 mg/kg;  n=6), (c) Saline, (i.e. 0.9% NACL; n=2). The Post Washout group 
had 7 days of continuous METH infusion followed by 7 days of no drug (i.e. METH) 
treatment. The treatment groups (n=12) were subjected to treatment of high dose METH 
(10 mg/kg) per day as illustrated in Figure 7 while the saline group was subjected to 
treatment of saline (i.e 0.9%  NaCl solution; n=2). The appropriate treatments were 
administered using an Alzet osmotic mini-perfusion pump for a period of 7 or 14 days at 
a rate of 1.0 µl per hour or 24 µl of saline in each 24-hour period 
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Figure 7. Treatment plan for all guinea pigs (n=29).  All of the guinea pigs did go through 
NOR (n=29). For electrophysiology (n=6) and molecular analysis (n=14) animals were 
randomly assigned. Out of the METH set two animals went through electrophysiology 
and six were used for molecular studies. Out of the saline set two animals went through 
the electrophysiology and the remaining two were further assessed for molecular studies. 
Out of the Post METH group two animals went through electrophysiology and six were 
used for molecular studies.  
 
 
 
 
 
 
Treatment Design  
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7 day METH Experimental Design 
 
Figure 8: Animals arrived on day 0 and were acclimatized for a period of 3-4 days. Alzet 
mini-pump implants were inserted on day 3. Drug treatments were performed on the 
same day for all guinea pigs (n=29).  Guinea pig handling occurred on day 7-9 for the 7 
day METH (n=10) and saline (n=2). NOR testing occurred on day 10. Euthanization of 
animals and tissue harvest occurred on days 11 and 12 for future molecular testing. 
 
 
 
 
Post Washout Experimental design 
 
Figure 9. Post washout period (n=12) occurred between days 9-15. GP handling for Post 
Washout (n=12) and Saline (n=3) occurred on days 16-18. NOR behavioral assessment 
occurred on day 19. Euthanization of animals and tissue harvest occurred on days 19-20 
for further molecular studies. 
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2.5 Behavioral Assessment 
The Novel Object Recognition test (NOR) is a behavioral task technique that is used to 
assess memory recall. Memory recall is a way to obtain information from your memory 
without having a cue or a trigger to activate past information or episode while recognition 
memory requires a trigger or a cue for memory activation of past information or episode 
(Haist et al., 1992 ). Recognition memory refers to the ability to judge a previously 
encountered item as familiar. Recognition memory is widely viewed as consisting of two 
components: recollection and familiarity (Malmberg, 2008; Atkinson and Juola, 1974). 
Recollection involves remembering specific contextual details about a prior learned 
episode and familiarity involves simply knowing that an item was presented, without 
having any available additional information about the learned episode. Tasks that assess 
recognition memory (and object recognition memory) in particular, have become 
increasingly useful tools for basic and preclinical research investigating the neural basis 
of memory (Winters et al. 2008). NOR consist of three phases: the familiarization phase, 
the delay phase, and the testing phase (Clark and Martin, 2005).  
2.5.1 Guinea Pig handling/Habituation 
 All guinea pigs (n=29) were handled for 5 minutes each day for 3 consecutive 
days to allow acclimatization to the testing environment and to the researcher. After the 
handling phase, the guinea pigs were allowed to explore and become familiar with the 
empty Nodulus Phenotyper, Home Cages (18.5 x 18.5), designated as the testing arena, 
(Leesburg, VA) for 5- additional minutes. In all experiments, the Phenotyper home cages 
were cleaned prior to each phase of the experiment. See Figure 10 for diagram of 
Phenotyper. 
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2.5.2 Re-habituation 
 At the beginning of the trial period, each guinea pig was placed in a Nodulus 
Phenotyper Home Cage and was allowed to explored the cage for 5 minutes. Guinea pigs 
were removed and placed in a transport box for 15 minutes, and two identical objects 
were placed in the Nodulus Phenotyper Home Cage. See Figures 11 and 12 for 
experimental diagram for the NOR test. 
 
2.5.3 Familiarization 
 The guinea pig was returned to the Nodulus Phenotyper Home Cage and allowed 
to explore the two identical objects for 5 minutes. 
 
2.5.4 Delay 
The guinea pig was removed from the Phenotyper Home Cage and taken back to 
his individual home cage for a 3 hour interval. During the delay phase a novel object 
along with one familiar object was placed in the Phenotyper Home Cage.  
 
2.5.5 Testing 
 After completion of the 3 hour delay interval, the guinea pig was returned to the 
Phenotyper Home Cage and was given the opportunity to explore the two objects, one 
which was novel for 5 minutes. See Figures 11 and 12 for NOR experimental schematic.  
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Nodulus Phenotyper 
 
 
 
 
 
Figure 10. Phentotyper where NOR assessment took place. The cage is 18.5” x 18.5” and 
equipped with a video tracker (A) which monitors the animal’s behavior and movement 
throughout the cage.  In this diagram B indicates the water bottle for the animal, and C 
indicates the door in which the animals enter the phenotyper. Adapted from 
http://www.noldus.com/.   
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2.5.6 Processing 
 
After the NOR tests were completed most of the guinea pigs  were euthanized with an 
overdose of pentobarbital (150 mg/kg body weight i.p.). Both hippocampi were harvested 
and preserved in RNAse Later (Ambion; Camarillo, CA) for subsequent molecular 
studies. Of the remaining guinea pigs, six were randomly selected to be processed electro 
physiologically to access synaptic changes in the hippocampus (see Electrophysiology 
section below).  
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Basic Novel Object Recognition Test 
 
 
 
Figure 11. The basic experimental layout for the NOR behavioral assessment test for the 
guinea pig (n=29) includes the familiarization phase, the exploration of two identical 
objects for 5 minutes, and the  test phase  which includes the exploration of two objects, 
one of which is novel, for 5 minutes after a 3 hour delay.  
 
 
 
 
Figure 12.  Basic experimental layout for the NOR behavioral assessment test for the 
guinea pigs (n=29) includes habituation, familiarization and, the Nor test (administered 
after a 3 hour interval). 
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2.5.7 Analysis: 
EthoVision XT (Nodulus,Virgina) software was used for the automatic tracking 
and analysis of animal movement, activity, and behavior in the Nodulus  Phenotyper. To 
assess recognition memory, the amount of time spent exploring the novel object verses 
the familial object was evaluated.  A discrimination index (DI) was calculated by 
subtracting the total time spent with the new object from the familiar object and dividing 
this value by the sum of the time spent exploring both objects. DI = (Time exploring 
NOV – Time exploring FAM)/ (Total time exploring NOV + FAM). A Positive DI values 
indicated a preference for the novel object which is suggestive of memory consolidation. 
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2.6 Electrophysiology  
  Guinea pigs were anesthetized with urethane (1500 mg/kg i.p.) dissolved in 
phosphate buffered saline (PBS) and were given Buprenorphine analgesic (.03 mg/kg; 
i.m.). To ensure that the animal was anesthetized, noxious stimulus such as pinching of 
the ear and hind limbs was done. If the animal twitched, withdrew a knee, or increased 
breathing was noticed, the animal was given a booster dosage of anesthesia, which was 
approximately 10-15% of the start dose. Each animal was firmly secured in a stereotaxic 
apparatus, with ear bars and mouth piece to stabilize the head. The top of the animal’s 
head was shaved and disinfected with alcohol wipes, after which, a subcutaneous 
injection of 2% lidocaine was injected under the skull as local anesthetic (0.2-0.3 mL). A 
circular patch of skin 2-3 cm was made to expose the skull. As needed hydrogen peroxide 
(30%) was used to clean the exposed skull to prevent further bleeding. The bregma was 
identified as the zero reference point for determining hippocampus coordinates for 
electrode placement.  Small access holes (~2 mm diameter) were made in the skull to 
allow for the lowering of bipolar tungsten stimulating electrodes (SNEX-15, Rhodes) in 
the left CA3 region (-4.5 mm posterior, 5 mm lateral and -5.0 mm vertical relative to 
bregma) and in the left CA1 region (-5.0 mm posterior, 2.5 mm lateral and -3.5mm 
vertical rise relative to bregma). Stimulation was applied to activate the CA3 neuron 
region and elicit population spike responses within the CA1 region. Once all electrodes 
were in place, recordings proceeded while monitoring vital signs. See Figure 13 for 
schematic of recording.  Appropriate measures were undertaken to make sure each 
animal remained fully anesthetized. To maximize animal comfort, during the recording 
guinea pigs were blanketed with warming pads in order to maintain regular body 
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temperature. Animal experiments were performed with strict adherence to protocols 
approved by the Institutional Animal Care and Use Committee. Stimuli were adjusted 
(100 -150 µA for 0.01 msec at 1 Hz) to evoke CA1 field potentials with amplitudes 
between 0.5 -1.0 mV. This response was monitored for 30 minutes. After the 30 minutes 
of stable recording, a high frequency tetanic stimulation was applied to elicit LTP (100 
Hz, 1sec, 3 trains at 60 sec intervals). The evoked population spikes were monitored for 
at least another 180 minutes at the original stimulation (100 -150 µA for 0.01 msec at 1 
Hz. The recorded population spike and spontaneous field potentials were amplified at a 
gain of 1000 X and filtered between 1Hz and 5 kHz using an AC amplifier. All 
population spike recordings that were acquired during the sessions were stored in the 
computer using pCLAMP10 software.  At the end of the recordings, the guinea pigs were 
euthanized with an overdose of pentobarbital (150 ml/kg body weight i.p.). The whole 
brain was immediately removed and stored in isopentane for subsequent molecular 
studies (i.e. in situ or Western blot).  
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Electrophsiology Recording  
 
 
 
 
Figure 13. An in vivo animal model. Stimulation in the left CA3 area evokes population 
spikes in the left CA1 sub-fields. We recorded spontaneous and evoked population spike 
in the left CA1 area only.  
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2.7 Analysis 
The basic parameters were extracted from the recorded field potentials and this 
included amplitude, onset latency, and duration. However only the change in the 
amplitude as a function of time was analyzed. The field potential typically has a positive-
going wave (PW1) that is interrupted by a negative-going population spike (PS), 
followed by another positive-going wave (PW2). PW1 reflects synaptic depolarization 
whereas PW2 corresponds to the input to CA1 cells (Anderson et al., 1964). The PS is 
due to a summation of discharging of CA1 neurons (Anderson et al., 1971).  The basic 
criterion for the detection of late-LTP was enhancement in post-conditioning synaptic 
responses, lasting beyond 2 hrs (one-way ANOVA with Scheffe’s test as the a posteriori 
test (α < 0.05)).  
 
2.8 Molecular Studies: 
 
2.8.1 Protein Isolation  
The total protein was isolated from frozen hippocampal tissue samples previously 
stored in RNA later. The tissue sample is first washed in PBS and the weight of the tissue 
sample was recorded before homogenization. About 600 µL (or 6-8 volumes per tissue 
mass) of ice-cold Cell Disruption Buffer (Invitrogen; Camarillo, CA) was added into a 
tube with the tissue sample and homogenized using the Pro 200 motor rotor-stator 
(Invitrogen; Camarillo, CA). The mixture was centrifuged at 16,000 x g for 20 minutes at 
4° C.  The pellet was then discarded and the supernatant, was aliquoted and stored until 
used.  
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2.8.2 Protein Concentration Determination via Bicinchoninic Acid Assay 
Protein concentration was measured using the Pierce Bicinchoninic Acid (BCA) 
Protein Assay as described by the manufacturer (Thermo Scientific, Rockland, IL). 
Bovine serum albumin (BSA) was used as a standard. This technique is based on the 
reduction of CU++ to CU+ by protein in an alkaline medium as follows: 
1. Protein (peptide bonds) + Cu++    tetradentate-Cu+ complex 
2. Cu++  +2 BCA     BCA-Cu+ complex (purple color) 
This purple color reaction product exhibits a strong absorbance at 562 nm that increases 
linearly with increasing protein concentration over a broad range of 20-2000 µg/ml. To 
determine the sample concentration, a plot was made of the values of BSA verses their 
known concentrations (ranging from 0 to 2000 µg/ml). A linear regression line was fitted 
from which the slope coefficient was calculated. At the same time several dilutions of 
each sample were also assayed and the calculation was obtained by taking the mean 
scored and dividing by the slope coefficient obtained from the BSA standard plot to 
obtain protein concentration for each sample.  
 
2.8.3 Protein Analysis    
Protein bands were separated according to their weights using the standard 
procedures of the NuPage MES kit on a precast 4-12% NuPAGE Novex  Bis-Tris Gel  
(Invitrogen; Camarillo, CA ). Individual samples were made according to the constituents 
shown in Table 1. Samples were heated for 10 minutes at 70°.   Proteins were 
electrophoresed and in duplicates using the  MES Running Buffer as shown in Table 3. 
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SDS-PAGE separation occurred for 35 min at 200V. After the completion of 
electrophoresis, the gels were transferred on a polyvinylidene fluoride (PVDF) membrane 
at 25V for 60 minutes using the Novex XCell blotting apparatus. The blotting sandwich 
was prepared and carefully inserted into the 1X transfer module in the Novex XCell unit 
with the transfer buffer. See Table 2 and Figure 14. 
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NUPAGE Reduced sample preparations 
 
Sample        20 μL 
NuPAGE® LDS Sample Buffer (4X)   2.5 μL 
NuPAGE® Antioxidant Reducing Agent   1 μL 
Deionized Water to      6.5 μL 
Total Volume       10 μL 
 
Table.1. Preparation of Reduced samples for denaturing gel electrophoresis using the 
NuPAGE  Novex Bis-Tris 
 
NUPAGE MES Running buffer  
 
NuPAGE SDS Running buffer (20X MOPS)  50 mL 
Deionized Water      950 mL 
Total Volume       1,000 mL 
 Table 3. Preparation of the Running buffer.  
 
NUPAGE MES Reduced Transfer buffer  
 
 
NuPAGE Transfer Buffer (20X)    50 mL 
NuPAGE® Antioxidant     1 mL 
METHanol       100 mL 
Deionized Water      849 mL 
Total Volume       1,000 mL 
 
Table.2. This transfer buffer was used during the transfer phase to ensure maximum 
protein transfer from the gel to the PVDF membrane.  
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Transfer Apparatus 
 
 
 
 
  
Figure 14. Depiction of Novex XCell II blotting apparatus set-up. Transfer sandwich was 
built from the base up with two blotting pad, filter paper, gel, PVDF transfer membrane, 
filter paper, and lastly blotting pad.  
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2.8.4 Western Blot Procedure for Alpha Synuclein 
 After the removal of the PVDF membrane from the transfer buffer, the membrane was 
washed briefly with 1X Tris-Buffered Saline and 10% Tween-20 (TBST). The membrane 
was rinsed off and incubated in blocking solution (10 ml of 5% milk in TBST) for 1 hour. 
15 µl of polyclonal rabbit  α synuclein (; Santa Cruz Biotechnology; Santa Cruz, CA, 
dilution 1:200) was added to 10 ml of 5% milk and the membrane was incubated overnight 
at room temperature. The following morning, the membrane was washed in three washes of 
TBST, 5 minutes each, and incubated with anti-rabbit secondary antibody conjugated to 
horseradish peroxidase (Bio-Rad, Hercules, CA) in 5% milk in TBST blocking solution for 
1hr at room temperature.  After the incubation, the membrane was washed in three washes 
of TBST, 5 minutes each. For signal development, the Detection Reagent Working 
Solution, Reagent 1 and Reagent 2, were used from the Fast ECL kit   (Thermoscientific, 
Rockland, IL). After mixing the Detection Reagent Working Solution in a 1:1 dilution, the 
solution was poured onto the membrane (approximately 3 ml of mixture per membrane). 
The detection reagent working solution interacted with the membrane for about 1 minute. 
The membrane was removed from the detection solution and was wrapped in a clear plastic 
wrap. The membrane was placed in a cassette tape and developed on film in a dark room 
for the appropriate time of 1 minute. Figure 15 shows a schematic of the Western blot 
procedure. 
After film exposure, the membrane was washed with TBST for 5 minutes to rinse 
off the detection agent. Membrane was re probed with 0.5 µl GAPDH  mouse 
monoclonal (Life Technologies; Camarillo, CA) in 10 ml of 5% milk/TBST incubated 
overnight at room temperature. Then, the membrane was removed from the antibody 
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solution and washed three times in TBST for 5 minutes. The membrane was then 
incubated with 0.5 µl   anti-mouse monoclonal (Santa Cruz Biotechnology; Santa Cruz, 
CA) for loading control purposes in 10 ml of 5% milk/TBST and immunoreactivity was 
visualized with the Fast ECL kit   (Thermoscientific, Rockland, IL) as described above. 
After development and exposure, the film was scanned and analyzed using the AlphaEase 
FC 4.0 (Alpha Innotech; San Leandro, CA).  
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Western Blot Procedure for Alpha Synuclein 
 
 
 
Figure 15. Flow Chart depicting molecular procedures used to assess α-syn expression in 
the guinea pig hippocampus after drug treatment with METH.  
 
 
1) Protein Isolation/ 
Determine protein 
concentration 
(BCA Kit) 
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Settings: 35min, 200V,  
125 mA 
3) Transfer on PVDF 
membranes 
Settings: 30V, 60 minutes, 
125 mA 
4) Block for an 1 hour  10 
ml of 5%milk/TBST 
5) Added polyclonal rabbit 
primary antibody (15µl  per 
10ml of 5% milk/TBST)  
overnight 
 
6)  Washes/ anti-rabbit 
seconary antibody 
conjugted HRP 
(5µL) per 10ml of 5% milk) 
1 hr 
7)  Wash/Expose to 
Detection Reagents from 
Fast ECL kit/ expose to film 
and analyze data 
8)  Strip/Add .5µl GAPDH 
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milk/TBST)  
9) Wash/Expose to 
Detection Reagents from 
Fast ECL kit/ expose  film 
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3. Results 
 
3.1 NOR Behavioral Assessment 
 
Twenty-nine animals were used to access recognition memory in the hippocampus. The 
technique used in this evaluation was the Novel Object Recognition (NOR) task that 
evaluated recognition memory, the amount of time spent exploring the novel object 
verses the familial object.  NOR was evaluated by using the Discrimination Index (DI). A 
discrimination index (DI) was calculated by subtracting the total time spent with the new 
object from the familiar object and dividing this value by the sum of the time spent 
exploring both objects. Figure 16 shows the discrimination index (DI) for the novel 
object for each subgroup (i.e., Saline, Post Washout, and METH).  Exploration of the 
objects by the guinea pigs (n=29) included sniffing, touching or time when the head 
region was within a defined perimeter around the object (FAM or NOV etc). On testing 
day the interval between familiarization and NOR testing was 3 hours. Both the Saline 
group and the Post Washout group exhibited a preference for the novel object on the 
NOR task as indicated by a positive DI. The important finding was that the Post Washout 
group exhibited preference for the novel object, but the METH group only showed a 
preference for the familiar object. The overall pattern of exploration through the NOR 
test was different in the three groups, but the Saline group (0.63 +/- 0.05) exhibited a 
much stronger preference for the novel object than did the Post Washout (0.15 +/- 0.06). 
Importantly, the METH group did have a preference for the familiar object (-0.21 +/- 
0.07) as shown in Figure 16. In fact, the METH group had a negative discrimination 
index which suggests this group did not have a preference for the novel object. This 
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affect by the METH group was statistically significant when compared to the saline 
groups (p > 0.05) using the 1-way ANOVA with Tukeys post-hoc tests.  
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Figure 16. A positive DI indicates a preference for the novel object and our results show 
guinea pigs in the saline group and Post Washout obtained positive scores on the NOR, 
i.e. showed preference for the novel object. While the METH group obtained a negative 
score on the NOR, i.e. did not show a preference for the novel object.  
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3.2 Electrophysiology 
 
3.2.1 Evoked Potentials 
Guinea Pigs (n=6) were used to evaluate the synaptic plasticity across the 
CA3/CA1 region of the hippocampus. CA3 afferent were stimulated to evoke population 
spikes in the CA1 region. For data analysis, the criteria for animal inclusion included 
recordings that exhibited stable evoked population spikes monitored for at least 30 
minutes. The evoked field potentials were typically comprised of an initial positive-going 
wave (PW) that was interrupted by a negative-going population spike (PS) followed by a 
second PW (Fig. 2). The first PW primarily reflects synaptic depolarization whereas the 
second PW corresponds to inhibitory influences occurring in CA1 cells. The population 
spike is due to the summation of CA1 neurons discharging, and we quantified it as ‘the 
vertical rise from peak negativity to the intersection point with a line drawn at a tangent 
between the two PWs’. Samples of evoked potentials (n=3) are shown in Figure 17. In all 
treatment groups pre-tetanus responses were successfully induced. With LTP taken to be 
at 40% increase in post tetanus potentials over baseline responses. It can be deduced that 
LTP was successfully induced in all groups at 60 minutes. The maintenance (180 
minutes) of the response was however not pronounced in the METH treated animals. The 
population spike amplitudes were not similar among the different animal groups and 
exhibited amplitudes ranging between 3-8 mV for 7-day METH treated animals, 3-12 
mV for the Post Washout animals, and 9-24 mV for Saline animals.. Taken together the 
high frequency tetanic stimulation (100 Hz, 1 sec, three trains at 60 sec intervals) 
produced both early-LTP and late-LTP in the Saline, Post Washout and METH groups. 
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LTP across the CA3/CA1 region was defined as 40% greater than pre-tetanus levels 
(100%). Results indicated that LTP was induced in all animal groups (n=3) but was more 
robust in the Saline treated animals (Figures 18-21). LTP was classified as (1) early-LTP 
(1-2 hours) and (2) late-LTP lasting beyond 2 hours. Presented in Figures 18-20 are 
individual time plots of population spikes for Saline (n=1), 7 day METH (n=1) and Post 
Washout (n=1). Figure 21 depicts the combine time plot of all treatment groups (n=3).  
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Figure 17. Evoked population spikes showing LTP in the different guinea pigs (n=3) 
hippocampus in vivo. The basic recording comprised of an initial positive-going wave 
(PW) followed by second PW. Population spike amplitude was measured as the vertical 
rise from peak negativity to the intersection point with a line drawn at a tangent between 
the two PWs.  
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Figure 18.  Saline time plot of LTP across CA3/CA1 synapses in guinea pig hippocampus 
in vivo.  The graph is a plot of individual population spikes over the duration of the 
experiment. Usually the pre tetanus response (last ten) is averaged together to get a pre-
tetanus baseline response. Briefly, LTP was observed as significant population spike 
enhancements of at least 40 % above pre-tetanus baseline responses. Early-LTP and late-
LTP was developed and maintained in the saline group (n=1).   
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Figure 19.  Time plot of the 7 day METH. LTP across CA3/CA1 synapses in guinea pig 
hippocampus in vivo.  The graph is a plot of individual population spikes over the 
duration of the experiment. Usually the pre tetanus response (last ten) is averaged 
together to get a pre-tetanus baseline response. Briefly, LTP was observed as significant 
population spike enhancements of at least 40 % above pre-tetanus baseline responses. 
Early-LTP and late-LTP was developed and maintained in the METH group (n=1).   
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Figure 20.  Time plot Post Washout of LTP across CA3/CA1 synapses in guinea pig 
hippocampus in vivo.  The graph is a plot of individual population spikes over the 
duration of the experiment. Usually the pre tetanus response (last ten) is averaged 
together to get a pre-tetanus baseline response. Briefly, LTP was observed as significant 
population spike enhancements of at least 40 % above pre-tetanus baseline responses. 
Early-LTP and late-LTP was developed and maintained in the Post METH group (n=1). 
L-LTP was more robust in Post Washout treatment group than the 7 day METH group.  
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Figure 21. A combined time plot of LTP across the CA3/CA1 synapses in the guinea pig 
(n=3) hippocampus in vivo. Briefly, LTP was observed as significant population spike 
enhancements of at least 40 % above pre-tetanus baseline responses. Early-LTP and late-
LTP were developed and maintained in all animal groups (n=3). However, L-LTP was 
more robust on the Saline-only control group.  
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3.2.2 Western blot  
 
For the quantitative assay, equal amounts of protein from the 3 treatment groups 
were electrophoresed concurrently. Samples were from taken from the 7 day METH 
(n=6), Post Washout (n=6), and Saline (n=2) groups. The samples were transferred onto 
the PVDF membranes, blotted with α-syn, developed and exposed to film as described in 
the Method section. In Figure 22 we found that hippocampal protein samples probed with 
polyclonal rabbit α-syn primary antibody (Santa Cruz Biotechnology; Santa Cruz, CA) 
yielded specific bands that matched the expected size of guinea pig α-syn at 17kda. We 
determined the densitometric measurements from the Western blots by using the Alpha 
Ease FC 4.0 software, normalized against GAPDH and charted the results using the 
Alpha Ease FC 4.0 software.  Figure 22 showed the α-syn band expression of a single gel. 
Figure 23 shows the histogram of the average densitometric measurement of individual 
α-syn  bands.  The results (Figures 22 and 23) indicate higher levels of α-syn present in 
the hippocampus of Saline-treated animals (n=2), and slightly decreased levels in the Post 
Washout (n=6) and the METH groups (n=6). Taken together, our data raised the prospect 
that there was a down regulation of endogenous α-syn protein levels in the hippocampus 
between subgroup classifications; however, these differences were not statistically 
significant.  
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Alpha Synuclein Western Blot Film 
 
 
 
 
 
 
 
Figure 22. Quantification of endogenous α-syn protein levels relative to the loading 
control (GAPDH). Each band within a subgroup represents an individual guinea pig.  
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Alpha Synuclein Densitometry  
 
 
 
 
 
Figure 23. Western blot depicts α-syn expression normalized to the control GAPDH. 
taken from the  7 day METH (n=6), Post Washout (i.e. 7 Day METH with WO; n=6), and 
Saline (n=2) groups . The Saline group (n=2) shows a higher densitometry.  
 
 
 
 
 
 
 
 
 
59 
 
4.  Discussion 
 
In the present study we investigated the memory performance of guinea pigs 
(n=29) under varying METH treatments. The METH group was continually exposed to 
METH (10mg/kg) per day for 7 days (n=10), Post Washout (n=12) was continually 
exposed to METH (10 mg/kg) per day for 7 days followed by 7 “washout” days, and the 
Saline group (n=7) was administered saline for 14 days and served as the control for this 
experiment. We assessed the behavioral component through a NOR test and the plasticity 
component through an Electrophysiology test to determine if memory consolidation 
occurred in the animals. Additionally, we determined the levels of α-syn, a biochemical 
marker that is implicated in neurodegenerative diseases such as Alzheimer’s and 
Dementia Lewy bodies in the hippocampus, a brain region known to be involved in the 
memory function. The key trends are that continual exposure to high dose METH results 
in a loss of object recognition.  
During the NOR behavioral assessment test, the guinea pigs (n=29) were given 5-
minute exposures to objects during the habituation, familiarization and the NOR phase 
and a discrimination index (DI) was assessed. We determined time spent exploring each 
object for the first 3 minutes during the different phases (i.e. Familiarization and NOR)  
as applicable to calculate the DI. Finally we calculated the DI particularly between novel 
object (NOV) and familiar object (FAM) as follows: DI = (Time exploring NOV – Time 
exploring FAM)/ (Total time exploring NOV + FAM). Positive DI values indicated a 
preference for the novel object which is suggestive of memory consolidation.  After the 
NOR test was assessed, the Saline group (n=7; DI= 0.63+/- 0.05) had the strongest 
preference for the novel object followed by the Post Washout group (n=12; DI= 0.15 +/- 
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0.06) and finally the METH group (n=10; DI= -0.21 +/- 0.07). As a consequence, we 
were able to obtain a reliable and robust measure of performance for the Saline group 
(n=7).  For  future studies, an increase in the delay time from 3 hours to 24 hours or 
longer can be used to see if memory consolidation was maintained between guinea pig 
subgroups. It is worth noting that in studies by  Luparini et al., (2000) when the period 
between the presentation of objects was increased (24 h) these groups lost the ability to 
recognize different objects. Increasing the time between the presentation of the familiar 
and the new object rendered animals unable to recognize novelty beyond 3 hours.  
In determining the effect METH has on synaptic plasticity,  a key finding was in 
the maintenance of late-LTP in animals treated with chronic METH (n=2). L-LTP was 
achieved and was not maintained can be attributed to (1) too few animals were used 
(n=2) and (2) the continuous infusion of METH in the brain may lead to a saturation 
effect. However, when there are not enough animals used for the study only trends can be 
suggested. One possible trend from the data is that METH treated animals may not 
maintain late-LTP. Additionally, due to the continuous infusion of METH, a saturation 
effect may have affected the process that lead to late-LTP. One possibility is that METH 
has desensitized the dopamine receptors. It is interesting to note that rats that have been 
treated chronically with METH for ninety days could not produce LTP (Chirwa et al., 
2005). It is suggestive from this data that the early and late phase of LTP was induced 
and but only the late phase was not sustained. The second key finding is the POST 
Washout group (n=2) that went through 7 days of continuous METH treatment followed 
by 7 days of “washout” which also showed the l-LTP was not maintained. The early 
phase of LTP was also induced in the hippocampus, but the late-LTP was not sustained 
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What is interesting in this group is that they showed a positive DI for the novel object 
during the NOR test which could suggest that after a “washout” period of METH 
memory recognition can be achieved. However, the guinea pig did show some signs of 
late-LTP but could not sustain it.  A very likely possibility is small sample size of the 
group (n=2) did not allow for sufficient data to be collected. A large group will give more 
information that will lead to a more definitive conclusion. 
In terms of molecular analysis of the guinea pig hippocampus expression, the 
focus was α-syn for several reasons including the implication of this protein in 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease whose major 
symptom is memory loss. According to Kokhan et al., at the molecular and cellular level 
α-syn deficient models may result in impairment of memory formation with aging 
animals (2011). Another study reported that abnormal accumulation of α-syn in the 
limbic system, particularly in the hippocampus, correlated with memory impairment and 
led to structural synaptic deficits (Lim et al., 2011). Furthermore, when α-syn expression 
was suppressed, partial clearing of pre-existing α-syn pathology and reversal of structural 
synaptic defects was observed, resulting in an improvement in memory function (Lim et 
al., 2011).  Interestingly when α-syn expression was investigated in the hippocampus of 
the guinea pigs for METH (n=6), Post Washout (n=6) and Saline (n=2) there was no 
statistical significance in the results once it was normalized with the loading control 
GAPDH. For instance, the present study did not measure the level of α-syn expressed in 
the guinea pigs before the experimental procedures.  Additionally, the lack of 
signifigance seen in  α-syn could be due to reduce sensitivity of the protocol. Also more 
sensitive tools areneeded such as probes with oligomers that are more specific and 
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sensitive to α-syn in order to make a definite conclusion or comparison. Another reason 
for the nature of protein expression could be the fact that METH can possibly alter α-syn 
through post-translational modification on different parts of the protein because α-syn can 
be over or under expressed A recent study by Lim et al., (2011) demonstrates the 
suppression of α-syn expression can lead to the memory improvement.  It is also a 
possibility that METH does not have an effect on α-syn expression since the function of 
α-syn is not widely known. We should have assessed protein or gene expression of α-syn 
through different points in the experiment to establish a pattern of change instead of the 
one point that we focused on.  Α-syn that is usually seen in neurodegenerative diseases in 
over expression or mutation could be trigged by other properties or mechanism in the 
brain that causes the abnormality seen in neurodegenerative disease. With regards to this 
project, the sample size was too small in order to effectively evaluate a mechanistic route 
for METH, α-syn, and memory loss connections. This is only a stepping stone for the 
effects of chronic METH on biochemical markers such as α-syn. 
In summary, the present findings suggests chronic METH administration has an 
affect on some of the same mechanisms underlining memory function and the drug-
induced activation lead to some form of memory impairments and the role of alpha 
synuclein in the process of  memory consolidation still remains unclear. 
 
 
 
 
 
63 
 
References  
 
1. Abraham, W. C., Dragunow, M., & Tate, W. P. (1991). The role of immediate 
early genes in the stabilization of long-term potentiation. Molecular 
Neurobiology, 5(2-4), 297-314.  
 
2. Adamczyk, A., Solecka, J., & Strosznajder, J. B. (2005). Expression of alpha-
synuclein in different brain parts of adult and aged rats. Journal of Physiology and 
Pharmacology : An Official Journal of the Polish Physiological Society, 56(1), 
29-37.  
 
3. Ahmad, B., & Lapidus, L. J. (2012). Curcumin prevents aggregation in alpha-
synuclein by increasing reconfiguration rate. The Journal of Biological 
Chemistry, 287(12), 9193-9199.  
 
4. Albertson, T. E., Derlet, R. W., & Van Hoozen, B. E. (1999). Methamphetamine 
and the expanding complications of amphetamines. The Western Journal of 
Medicine, 170(4), 214-219.  
 
5. Ares-Santos, S., Granado, N., Oliva, I., O'Shea, E., Martin, E. D., Colado, M. I., 
et al. (2011). Dopamine D(1) receptor deletion strongly reduces neurotoxic effects 
of methamphetamine. Neurobiology of Disease, 45(2), 810-820.  
 
6. Aron, J. L., & Paulus, M. P. (2007). Location, location: Using functional 
magnetic resonance imaging to pinpoint brain differences relevant to stimulant 
use. Addiction (Abingdon, England), 102 Suppl 1, 33-43.  
 
7. Baddeley, A., Bueno, O., Cahill, L., Fuster, J. M., Izquierdo, I., McGaugh, J. L., 
et al. (2000). The brain decade in debate: I. neurobiology of learning and memory. 
Brazilian Journal of Medical and Biological Research = Revista Brasileira De 
Pesquisas Medicas e Biologicas / Sociedade Brasileira De Biofisica ...[Et Al.], 
33(9), 993-1002.  
 
8. Baddeley, A., Jarrold, C., & Vargha-Khadem, F. (2011). Working memory and 
the hippocampus. Journal of Cognitive Neuroscience,23 (12) 3855-61. 
  
9. Ballarini, F., Moncada, D., Martinez, M. C., Alen, N., & Viola, H. (2009). 
Behavioral tagging is a general mechanism of long-term memory formation. 
Proceedings of the National Academy of Sciences of the United States of America, 
106(34), 14599-14604.  
 
10. Bannon, M. J. (2005). The dopamine transporter: Role in neurotoxicity and 
human disease. Toxicology and Applied Pharmacology, 204(3), 355-360.  
64 
 
11. Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., 
Honer, W. G. (2006). The need for speed: An update on methamphetamine 
addiction. Journal of Psychiatry & Neuroscience : JPN, 31(5), 301-313.  
 
12. Bartels, T., Choi, J. G., & Selkoe, D. J. (2011). Alpha-synuclein occurs 
physiologically as a helically folded tetramer that resists aggregation. Nature, 
477(7362), 107-110.  
 
13. Belcher, A. M., O'Dell, S. J., & Marshall, J. F. (2005). Impaired object 
recognition memory following methamphetamine, but not p-chloroamphetamine- 
or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology : Official 
Publication of the American College of Neuropsychopharmacology, 30(11), 2026-
2034.  
 
14. Beraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K. (2011). 
Alpha-synuclein alters toll-like receptor expression. Frontiers in Neuroscience, 5, 
80.  
 
15. Best, J. D., Berghmans, S., Hunt, J. J., Clarke, S. C., Fleming, A., Goldsmith, P. 
(2008). Non-associative learning in larval zebrafish. Neuropsychopharmacology : 
Official Publication of the American College of Neuropsychopharmacology, 
33(5), 1206-1215.  
 
16. Bjorklund, A., & Lindvall, O. (1975). Dopamine in dendrites of substantia nigra 
neurons: Suggestions for a role in dendritic terminals. Brain Research, 83(3), 531-
537.  
 
17. Bliss, T. V., & Lomo, T. (1973). Long-lasting potentiation of synaptic 
transmission in the dentate area of the anaesthetized rabbit following stimulation 
of the perforant path. The Journal of Physiology, 232(2), 331-356.  
 
18. Bowyer, J. F., & Ali, S. (2006). High doses of methamphetamine that cause 
disruption of the blood-brain barrier in limbic regions produce extensive neuronal 
degeneration in mouse hippocampus. Synapse (New York, N.Y.), 60(7), 521-532.  
 
19. Braak, H., Sandmann-Keil, D., Gai, W., & Braak, E. (1999). Extensive axonal 
lewy neurites in parkinson's disease: A novel pathological feature revealed by 
alpha-synuclein immunocytochemistry. Neuroscience Letters, 265(1), 67-69.  
 
20. Brecht, M. L., O'Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004). 
Methamphetamine use behaviors and gender differences. Addictive Behaviors, 
29(1), 89-106.  
 
21. Broadbent, N. J., Gaskin, S., Squire, L. R., & Clark, R. E. (2009). Object 
recognition memory and the rodent hippocampus. Learning & Memory (Cold 
Spring Harbor, N.Y.), 17(1), 5-11.  
65 
 
22. Brown, J. M., Hanson, G. R., & Fleckenstein, A. E. (2001). Regulation of the 
vesicular monoamine transporter-2: A novel mechanism for cocaine and other 
psychostimulants. The Journal of Pharmacology and Experimental Therapeutics, 
296(3), 762-767.  
 
23. Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007). Structural and metabolic 
brain changes in the striatum associated with methamphetamine abuse. Addiction 
(Abingdon, England), 102 Suppl 1, 16-32.  
 
24. Cherner, M., Suarez, P., Casey, C., Deiss, R., Letendre, S., Marcotte, T. (2010). 
Methamphetamine use parameters do not predict neuropsychological impairment 
in currently abstinent dependent adults. Drug and Alcohol Dependence, 106(2-3), 
154-163.  
 
25. Chirwa, S., Aduonum, A., Pizarro, J., Reasor, J., Kawai, Y., Gonzalez, M.(2005). 
Dopaminergic DA1 signaling couples growth-associated protein-43 and long-term 
potentiation in guinea pig hippocampus. Brain Research Bulletin, 64(5), 433-440.  
 
26. Clark, R. E., & Martin, S. J. (2005). Interrogating rodents regarding their object 
and spatial memory. Current Opinion in Neurobiology, 15(5), 593-598. 
 
27. Clark, R. E., Zola, S. M., & Squire, L. R. (2000). Impaired recognition memory in 
rats after damage to the hippocampus. The Journal of Neuroscience : The Official 
Journal of the Society for Neuroscience, 20(23), 8853-8860.  
 
28. Clarke, J. R., Cammarota, M., Gruart, A., Izquierdo, I., & Delgado-Garcia, J. M. 
(2010). Plastic modifications induced by object recognition memory processing. 
Proceedings of the National Academy of Sciences of the United States of America, 
107(6), 2652-2657.  
 
29. Clayton, D. F., & George, J. M. (1998). The synucleins: A family of proteins 
involved in synaptic function, plasticity, neurodegeneration and disease. Trends in 
Neurosciences, 21(6), 249-254.  
 
30. Cohen, N. J., & Squire, L. R. (1980). Preserved learning and retention of pattern-
analyzing skill in amnesia: Dissociation of knowing how and knowing that. 
Science (New York, N.Y.), 210(4466), 207-210.  
 
31. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., & 
Lansbury, P. T.,Jr. (2000). Acceleration of oligomerization, not fibrillization, is a 
shared property of both alpha-synuclein mutations linked to early-onset 
parkinson's disease: Implications for pathogenesis and therapy. Proceedings of the 
National Academy of Sciences of the United States of America, 97(2), 571-576.  
 
32. Cooper, S. J. (2005). Donald O. hebb's synapse and learning rule: A history and 
commentary. Neuroscience and Biobehavioral Reviews, 28(8), 851-874.  
66 
 
33. Costa-Mattioli, M. (2008). Eppendorf winner. Switching memories ON and OFF. 
Science (New York, N.Y.), 322(5903), 874-875.  
 
34. Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., & Hall, J. A. (2003). 
Treatment of methamphetamine abuse: Research findings and clinical directions. 
Journal of Substance Abuse Treatment, 24(3), 267-277.  
 
35. Crews, L., Tsigelny, I., Hashimoto, M., & Masliah, E. (2009). Role of synucleins 
in alzheimer's disease. Neurotoxicity Research, 16(3), 306-317.  
 
36. Crowther, R. A., Jakes, R., Spillantini, M. G., & Goedert, M. (1998). Synthetic 
filaments assembled from C-terminally truncated alpha-synuclein. FEBS Letters, 
436(3), 309-312.  
 
37. Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and 
psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 
253-262.  
 
38. Devine, M. J., Gwinn, K., Singleton, A., & Hardy, J. (2011). Parkinson's disease 
and alpha-synuclein expression. Movement Disorders : Official Journal of the 
Movement Disorder Society, 26(12):2160-8  
 
39. Dragunow, M. (1996). A role for immediate-early transcription factors in learning 
and memory. Behavior Genetics, 26(3), 293-299.  
 
40. Ennaceur, A. (2010). One-trial object recognition in rats and mice: 
Methodological and theoretical issues. Behavioural Brain Research, 215(2), 244-
254.  
 
41. Fanselow, M. S. (2010). From contextual fear to a dynamic view of memory 
systems. Trends in Cognitive Sciences, 14(1), 7-15.  
 
42. Finkbeiner, S., & Greenberg, M. E. (1998). Ca2+ channel-regulated neuronal 
gene expression. Journal of Neurobiology, 37(1), 171-189.  
 
43. Forno, L. S. (1996). Neuropathology of parkinson's disease. Journal of 
Neuropathology and Experimental Neurology, 55(3), 259-272.  
 
44. French, P. J., O'Connor, V., Jones, M. W., Davis, S., Errington, M. L., Voss, K., 
et al. (2001). Subfield-specific immediate early gene expression associated with 
hippocampal long-term potentiation in vivo. The European Journal of 
Neuroscience, 13(5), 968-976.  
 
45. Gengler, S., Hamilton, A., & Holscher, C. (2010). Synaptic plasticity in the 
hippocampus of a APP/PS1 mouse model of alzheimer's disease is impaired in old 
but not young mice. PloS One, 5(3), e9764.  
67 
 
46. George, J. M. (2002). The synucleins. Genome Biology, 3(1), REVIEWS3002. 
  
47. Ghosh, A., & Greenberg, M. E. (1995). Calcium signaling in neurons: Molecular 
mechanisms and cellular consequences. Science (New York, N.Y.), 268(5208), 
239-247.  
 
48. Ginty, D. D. (1997). Calcium regulation of gene expression: Isn't that spatial? 
Neuron, 18(2), 183-186.  
 
49. Gold, P. E., van Buskirk, R. B., & McGaugh, J. L. (1975). Effects of hormones on 
time-dependent memory storage processes. Progress in Brain Research, 42, 210-
211.  
 
50. Goldman-Rakic, P. S. (1992). Working memory and the mind. Scientific 
American, 267(3), 110-117.  
 
51. Gonzales, R., Ang, A., McCann, M. J., & Rawson, R. A. (2008). An emerging 
problem: Methamphetamine abuse among treatment seeking youth. Substance 
Abuse: Official Publication of the Association for Medical Education and 
Research in Substance Abuse, 29(2), 71-80.  
 
52. Gonzalez, R., Bechara, A., & Martin, E. M. (2007). Executive functions among 
individuals with methamphetamine or alcohol as drugs of choice: Preliminary 
observations. Journal of Clinical and Experimental Neuropsychology, 29(2), 155-
159. 
 
53. Good, R. L., Liang, L. P., Patel, M., & Radcliffe, R. A. (2011). Mouse strain- and 
age-dependent effects of binge methamphetamine on dopaminergic signaling. 
Neurotoxicology, 32(6), 751-759.  
 
54. Grady, C. L., Furey, M. L., Pietrini, P., Horwitz, B., & Rapoport, S. I. (2001). 
Altered brain functional connectivity and impaired short-term memory in 
alzheimer's disease. Brain: A Journal of Neurology, 124(Pt 4), 739-756.  
 
55. Greenberg, M. E., Ziff, E. B., & Greene, L. A. (1986). Stimulation of neuronal 
acetylcholine receptors induces rapid gene transcription. Science (New York, 
N.Y.), 234(4772), 80-83.  
 
56. Gureviciene, I., Gurevicius, K., & Tanila, H. (2007). Role of alpha-synuclein in 
synaptic glutamate release. Neurobiology of Disease, 28(1), 83-89.  
 
57. Guzowski, J. F. (2002). Insights into immediate-early gene function in 
hippocampal memory consolidation using antisense oligonucleotide and 
fluorescent imaging approaches. Hippocampus, 5; 12(3; 1), 86-104.  
68 
 
58. Haist, F., Shimamura, A. P., & Squire, L. R. (1992). On the relationship between 
recall and recognition memory. Journal of Experimental Psychology.Learning, 
Memory, and Cognition, 18(4), 691-702.  
 
59. Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H. 
(2005). Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra 
early in parkinson's disease. Brain: A Journal of Neurology, 128(Pt 11), 2654-
2664.  
 
60. Hardingham, G. E., Arnold, F. J., & Bading, H. (2001). Nuclear calcium signaling 
controls CREB-mediated gene expression triggered by synaptic activity. Nature 
Neuroscience, 4(3), 261-267.  
 
61. Hart, C. L., Marvin, C. B., Silver, R., & Smith, E. E. (2012). Is cognitive 
functioning impaired in methamphetamine users? A critical review. 
Neuropsychopharmacology: Official Publication of the American College of 
Neuropsychopharmacology, 37(3), 586-608.  
 
62. Hashimoto, M., Rockenstein, E., Crews, L., & Masliah, E. (2003). Role of protein 
aggregation in mitochondrial dysfunction and neurodegeneration in alzheimer's 
and parkinson's diseases. Neuromolecular Medicine, 4(1-2), 21-36.  
 
63. Hirsh, R. (1974). The hippocampus and contextual retrieval of information from 
memory: A theory. Behavioral Biology, 12(4), 421-444.  
 
64. Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J., & 
Mitchell, S. H. (2006). Neuropsychological function and delay discounting in 
methamphetamine-dependent individuals. Psychopharmacology, 188(2), 162-170.  
 
65. Homer, B. D., Solomon, T. M., Moeller, R. W., Mascia, A., DeRaleau, L., & 
Halkitis, P. N. (2008). Methamphetamine abuse and impairment of social 
functioning: A review of the underlying neurophysiological causes and behavioral 
implications. Psychological Bulletin, 134(2), 301-310.  
 
66. Hotte, M., Dauphin, F., Freret, T., Boulouard, M., & Levallet, G. (2012). A 
biphasic and brain-region selective down-regulation of cyclic adenosine 
monophosphate concentrations supports object recognition in the rat. PloS One, 
7(2), e32244.  
 
67. Huang, Y. Y., & Kandel, E. R. (1994). Recruitment of long-lasting and protein 
kinase A-dependent long-term potentiation in the CA1 region of hippocampus 
requires repeated tetanization. Learning & Memory (Cold Spring Harbor, N.Y.), 
1(1), 74-82.  
 
68. Huang, Y. Y., & Kandel, E. R. (1998). Postsynaptic induction and PKA-
dependent expression of LTP in the lateral amygdala. Neuron, 21(1), 169-178.  
69 
 
69. Huang, Y. Y., Pittenger, C., & Kandel, E. R. (2004). A form of long-lasting, 
learning-related synaptic plasticity in the hippocampus induced by heterosynaptic 
low-frequency pairing. Proceedings of the National Academy of Sciences of the 
United States of America, 101(3), 859-864. 
 
70. Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural mechanisms of 
addiction: The role of reward-related learning and memory. Annual Review of 
Neuroscience, 29, 565-598.  
 
71. Ishikawa, A., Kadota, T., Kadota, K., Matsumura, H., & Nakamura, S. (2005). 
Essential role of D1 but not D2 receptors in methamphetamine-induced 
impairment of long-term potentiation in hippocampal-prefrontal cortex pathway. 
The European Journal of Neuroscience, 22(7), 1713-1719.  
 
72. Iudicello, J. E., Woods, S. P., Vigil, O., Scott, J. C., Cherner, M., Heaton, R. 
K.(2010). Longer term improvement in neurocognitive functioning and affective 
distress among methamphetamine users who achieve stable abstinence. Journal of 
Clinical and Experimental Neuropsychology, 32(7), 704-718. 
 
73. Iwai, A. (2000). Properties of NACP/alpha-synuclein and its role in alzheimer's 
disease. Biochimica Et Biophysica Acta, 1502(1), 95-109.  
 
74. Iyo, M., Sekine, Y., & Mori, N. (2004). Neuromechanism of developing 
methamphetamine psychosis: A neuroimaging study. Annals of the New York 
Academy of Sciences, 1025, 288-295.  
 
75. Izquierdo, I. (1994). Pharmacological evidence for a role of long-term 
potentiation in memory. FASEB Journal : Official Publication of the Federation 
of American Societies for Experimental Biology, 8(14), 1139-1145.  
 
76. Izquierdo, I., Medina, J. H., Vianna, M. R., Izquierdo, L. A., & Barros, D. M. 
(1999). Separate mechanisms for short- and long-term memory. Behavioural 
Brain Research, 103(1), 1-11.  
 
77. Jedynak, J. P., Uslaner, J. M., Esteban, J. A., & Robinson, T. E. (2007). 
Methamphetamine-induced structural plasticity in the dorsal striatum. The 
European Journal of Neuroscience, 25(3), 847-853.  
 
78. Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998). Regulation of 
phospholipase D2: Selective inhibition of mammalian phospholipase D 
isoenzymes by alpha- and beta-synucleins. Biochemistry, 37(14), 4901-4909. 
  
79. Johannessen, M., Delghandi, M. P., & Moens, U. (2004). What turns CREB on? 
Cellular Signalling, 16(11), 1211-1227.  
 
70 
 
80. Jones, S., & Bonci, A. (2005). Synaptic plasticity and drug addiction. Current 
Opinion in Pharmacology, 5(1), 20-25.  
 
81. Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine 
dependence is associated with neurocognitive impairment in the initial phases of 
abstinence. The Journal of Neuropsychiatry and Clinical Neurosciences, 15(2), 
215-220. 
 
82. Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: A 
pathology of motivation and choice. The American Journal of Psychiatry, 162(8), 
1403-1413.  
 
83. Kamei, H., Nagai, T., Nakano, H., Togan, Y., Takayanagi, M., Takahashi, K. 
(2006). Repeated methamphetamine treatment impairs recognition memory 
through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of 
mice. Biological Psychiatry, 59(1), 75-84.  
 
84. Kandel, E. R. (2009). The biology of memory: A forty-year perspective. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
29(41), 12748-12756.  
 
85. Kandel, E. R., & Schwartz, J. H. (1982). Molecular biology of learning: 
Modulation of transmitter release. Science (New York, N.Y.), 218(4571), 433-443.  
 
86. Kaplan, B., Ratner, V., & Haas, E. (2003). Alpha-synuclein: Its biological 
function and role in neurodegenerative diseases. Journal of Molecular 
Neuroscience: MN, 20(2), 83-92.  
 
87. Kauer, J. A., Malenka, R. C., & Nicoll, R. A. (1988). A persistent postsynaptic 
modification mediates long-term potentiation in the hippocampus. Neuron, 1(10), 
911-917.  
 
88. Kholodilov, N. G., Neystat, M., Oo, T. F., Lo, S. E., Larsen, K. E., Sulzer, D. 
(1999). Increased expression of rat synuclein in the substantia nigra pars 
compacta identified by mRNA differential display in a model of developmental 
target injury. Journal of Neurochemistry, 73(6), 2586-2599.  
 
89. Khoshbouei, H., Wang, H., Lechleiter, J. D., Javitch, J. A., & Galli, A. (2003). 
Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular 
na+-dependent mechanism. The Journal of Biological Chemistry, 278(14), 12070-
12077.  
 
90. Kidambi, S., Yarmush, J., Berdichevsky, Y., Kamath, S., Fong, W., & 
Schianodicola, J. (2010). Propofol induces MAPK/ERK cascade dependant 
expression of cFos and egr-1 in rat hippocampal slices. BMC Research Notes, 3, 
201.  
71 
 
91. Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A., Velasco, I., Gavin, D., 
Lumelsky, N. (2002). Dopamine neurons derived from embryonic stem cells 
function in an animal model of parkinson's disease. Nature, 418(6893), 50-56.  
 
92. Kim, S., Seo, J. H., & Suh, Y. H. (2004). Alpha-synuclein, parkinson's disease, 
and alzheimer's disease. Parkinsonism & Related Disorders, 10 Suppl 1, S9-13.  
 
93. Kirik, D., Annett, L. E., Burger, C., Muzyczka, N., Mandel, R. J., & Bjorklund, 
A. (2003). Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated 
overexpression of human alpha-synuclein: A new primate model of parkinson's 
disease. Proceedings of the National Academy of Sciences of the United States of 
America, 100(5), 2884-2889.  
 
94. Kiyatkin, E. A., Brown, P. L., & Sharma, H. S. (2007). Brain edema and 
breakdown of the blood-brain barrier during methamphetamine intoxication: 
Critical role of brain hyperthermia. The European Journal of Neuroscience, 26(5), 
1242-1253.  
 
95. Kobayashi, H., Ide, S., Hasegawa, J., Ujike, H., Sekine, Y., Ozaki, N. (2004). 
Study of association between alpha-synuclein gene polymorphism and 
methamphetamine psychosis/dependence. Annals of the New York Academy of 
Sciences, 1025, 325-334.  
 
96. Konradi, C., Cole, R. L., Heckers, S., & Hyman, S. E. (1994). Amphetamine 
regulates gene expression in rat striatum via transcription factor CREB. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
14(9), 5623-5634.  
 
97. Konradi, C., Leveque, J. C., & Hyman, S. E. (1996). Amphetamine and 
dopamine-induced immediate early gene expression in striatal neurons depends 
on postsynaptic NMDA receptors and calcium. The Journal of Neuroscience: The 
Official Journal of the Society for Neuroscience, 16(13), 4231-4239.  
 
98. Krasnova, I. N., & Cadet, J. L. (2009). Methamphetamine toxicity and 
messengers of death. Brain Research Reviews, 60(2), 379-407.  
 
99. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S. (1998). 
Ala30Pro mutation in the gene encoding alpha-synuclein in parkinson's disease. 
Nature Genetics, 18(2), 106-108.  
 
100. Kubik, S., Miyashita, T., & Guzowski, J. F. (2007). Using immediate-early genes 
to map hippocampal subregional functions. Learning & Memory (Cold Spring 
Harbor, N.Y.), 14(11), 758-770.  
 
101. Kuczenski, R., Segal, D. S., Melega, W. P., Lacan, G., & McCunney, S. J. 
(2009). Human methamphetamine pharmacokinetics simulated in the rat: 
72 
 
Behavioral and neurochemical effects of a 72-h binge. 
Neuropsychopharmacology : Official Publication of the American College of 
Neuropsychopharmacology, 34(11), 2430-2441.  
 
102. Kurz, A., Double, K. L., Lastres-Becker, I., Tozzi, A., Tantucci, M., Bockhart, 
V. (2010). A53T-alpha-synuclein overexpression impairs dopamine signaling and 
striatal synaptic plasticity in old mice. PloS One, 5(7), e11464.  
 
103. Lavedan, C. (1998). The synuclein family. Genome Research, 8(9), 871-880.  
 
104. Lee, H. G., Zhu, X., Takeda, A., Perry, G., & Smith, M. A. (2006). Emerging 
evidence for the neuroprotective role of alpha-synuclein. Experimental 
Neurology, 200(1), 1-7.  
 
105. Li, L., Everhart, T., Jacob Iii, P., Jones, R., & Mendelson, J. (2010). 
Stereoselectivity in the human metabolism of methamphetamine. British Journal 
of Clinical Pharmacology, 69(2), 187-192.  
 
106. Lim, Y., Kehm, V. M., Lee, E. B., Soper, J. H., Li, C., Trojanowski, J. Q. (2011). 
Alpha-syn suppression reverses synaptic and memory defects in a mouse model 
of dementia with lewy bodies. The Journal of Neuroscience: The Official Journal 
of the Society for Neuroscience, 31(27), 10076-10087.  
 
107. Lim, Y., Kehm, V. M., Lee, E. B., Soper, J. H., Li, C., Trojanowski, J. Q. (2000). 
Alpha-syn suppression reverses synaptic and memory defects in a mouse model 
of dementia with lewy bodies; synucleins are developmentally expressed, and 
alpha-synuclein regulates the size of the presynaptic vesicular pool in primary 
hippocampal neurons. The Journal of Neuroscience: The Official Journal of the 
Society for Neuroscience, 31; 20(27; 9), 10076; 3214-10087; 3220.  
 
108. Liu, S., Fa, M., Ninan, I., Trinchese, F., Dauer, W., & Arancio, O. (2007). 
Alpha-synuclein involvement in hippocampal synaptic plasticity: Role of NO, 
cGMP, cGK and CaMKII. The European Journal of Neuroscience, 25(12), 3583-
3596.  
 
109. Lonze, B. E., & Ginty, D. D. (2002). Function and regulation of CREB family 
transcription factors in the nervous system. Neuron, 35(4), 605-623.  
 
110. Lucot, J. B., Wagner, G. C., Schuster, C. R., & Seiden, L. S. (1980). The effects 
of dopaminergic agents on the locomotor activity of rats after high doses of 
methylamphetamine. Pharmacology, Biochemistry, and Behavior, 13(3), 409-413.  
 
111. Mahoney, J. J.,3rd, Jackson, B. J., Kalechstein, A. D., De la Garza, R.,2nd, & 
Newton, T. F. (2011). Acute, low-dose methamphetamine administration 
improves attention/information processing speed and working memory in 
methamphetamine-dependent individuals displaying poorer cognitive 
73 
 
performance at baseline. Progress in Neuro-Psychopharmacology & Biological 
Psychiatry, 35(2), 459-465.  
 
112. Makisumi, T., Yoshida, K., Watanabe, T., Tan, N., Murakami, N., & Morimoto, 
A. (1998). Sympatho-adrenal involvement in methamphetamine-induced 
hyperthermia through skeletal muscle hypermetabolism. European Journal of 
Pharmacology, 363(2-3), 107-112.  
 
113. Malenka, R. C., & Bear, M. F. (2004). LTP and LTD: An embarrassment of 
riches. Neuron, 44(1), 5-21.  
 
114. Malenka, R. C., Kauer, J. A., Zucker, R. S., & Nicoll, R. A. (1988). Postsynaptic 
calcium is sufficient for potentiation of hippocampal synaptic transmission. 
Science (New York, N.Y.), 242(4875), 81-84.  
 
115. Malleret, G., Alarcon, J. M., Martel, G., Takizawa, S., Vronskaya, S., Yin, D. 
(2010). Bidirectional regulation of hippocampal long-term synaptic plasticity and 
its influence on opposing forms of memory. The Journal of Neuroscience: The 
Official Journal of the Society for Neuroscience, 30(10), 3813-3825.  
 
116. Mantle, T. J., Tipton, K. F., & Garrett, N. J. (1976). Inhibition of monoamine 
oxidase by amphetamine and related compounds. Biochemical Pharmacology, 
25(18), 2073-2077.  
 
117. Marinescu, V., Loomis, P. A., Ehmann, S., Beales, M., & Potashkin, J. A. 
(2007). Regulation of retention of FosB intron 4 by PTB. PloS One, 2(9), e828.  
 
118. Maroteaux, L., Campanelli, J. T., & Scheller, R. H. (1988). Synuclein: A neuron-
specific protein localized to the nucleus and presynaptic nerve terminal. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
8(8), 2804-2815.  
119. Marr, D. (1971). Simple memory: A theory for archicortex. Philosophical 
Transactions of the Royal Society of London.Series B, Biological Sciences, 
262(841), 23-81.  
 
120. Marshall, J. F., Belcher, A. M., Feinstein, E. M., & O'Dell, S. J. (2007). 
Methamphetamine-induced neural and cognitive changes in rodents. Addiction 
(Abingdon, England), 102 Suppl 1, 61-69.  
 
121. Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. 
C. (2011). Alpha-synuclein oligomers oppose long-term potentiation and impair 
memory through a calcineurin-dependent mechanism: Relevance to human 
synucleopathic diseases. Journal of Neurochemistry, 120(3):440-52 
 
122. Martins, T., Baptista, S., Goncalves, J., Leal, E., Milhazes, N., Borges, F. (2011). 
Methamphetamine transiently increases the blood-brain barrier permeability in the 
74 
 
hippocampus: Role of tight junction proteins and matrix metalloproteinase-9. 
Brain Research, 1411, 28-40.  
 
123. Mauceli, G., Busceti, C. I., Pellegrini, A., Soldani, P., Lenzi, P., Paparelli, A. 
(2006). Overexpression of alpha-synuclein following methamphetamine: Is it 
good or bad? Annals of the New York Academy of Sciences, 1074, 191-197.  
 
124. McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & 
Ricaurte, G. A. (1998). Reduced striatal dopamine transporter density in abstinent 
methamphetamine and methcathinone users: Evidence from positron emission 
tomography studies with [11C]WIN-35,428. The Journal of Neuroscience: The 
Official Journal of the Society for Neuroscience, 18(20), 8417-8422.  
 
125. McClung, C. A., & Nestler, E. J. (2008). Neuroplasticity mediated by altered 
gene expression. Neuropsychopharmacology: Official Publication of the 
American College of Neuropsychopharmacology, 33(1), 3-17.  
 
126. McGaugh, J. L. (1966). Time-dependent processes in memory storage. Science 
(New York, N.Y.), 153(3742), 1351-1358.  
 
127. McGaugh, J. L. (2000). Memory--a century of consolidation. Science (New York, 
N.Y.), 287(5451), 248-251.  
 
128. Meberg, P. J., Valcourt, E. G., & Routtenberg, A. (1995). Protein F1/GAP-43 
and PKC gene expression patterns in hippocampus are altered 1-2 h after LTP. 
Brain Research.Molecular Brain Research, 34(2), 343-346.  
 
129. Melo, P., Magalhaes, A., Alves, C. J., Tavares, M. A., de Sousa, L., 
Summavielle, T.. (2012). Methamphetamine mimics the neurochemical profile of 
aging in rats and impairs recognition memory. Neurotoxicology, 33(3):491-9 
 
130. Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005). Implications of 
chronic methamphetamine use: A literature review. Harvard Review of 
Psychiatry, 13(3), 141-154.  
 
131. Moncada, D., & Viola, H. (2007). Induction of long-term memory by exposure 
to novelty requires protein synthesis: Evidence for a behavioral tagging. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
27(28), 7476-7481.  
 
132. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. (2000). 
Synucleins are developmentally expressed, and alpha-synuclein regulates the size 
of the presynaptic vesicular pool in primary hippocampal neurons. The Journal of 
Neuroscience: The Official Journal of the Society for Neuroscience, 20(9), 3214-
3220.  
75 
 
133. Murray, J. B. (1998). Psychophysiological aspects of amphetamine-
methamphetamine abuse. The Journal of Psychology, 132(2), 227-237.  
 
134. Nagai, T., Takuma, K., Dohniwa, M., Ibi, D., Mizoguchi, H., Kamei, H. (2007). 
Repeated methamphetamine treatment impairs spatial working memory in rats: 
Reversal by clozapine but not haloperidol. Psychopharmacology, 194(1), 21-32.  
 
135. Nasstrom, T., Goncalves, S., Sahlin, C., Nordstrom, E., Screpanti Sundquist, V., 
Lannfelt, L., et al. (2011). Antibodies against alpha-synuclein reduce 
oligomerization in living cells. PloS One, 6(10), e27230.  
 
136. Nestler, E. J. (2004). Molecular mechanisms of drug addiction. 
Neuropharmacology, 47 Suppl 1, 24-32.  
 
137. Nguyen, P. V., & Woo, N. H. (2003). Regulation of hippocampal synaptic 
plasticity by cyclic AMP-dependent protein kinases. Progress in Neurobiology, 
71(6), 401-437.  
 
138. Norris, E. H., Giasson, B. I., & Lee, V. M. (2004). Alpha-synuclein: Normal 
function and role in neurodegenerative diseases. Current Topics in Developmental 
Biology, 60, 17-54.  
 
139. O'Dell, T. J., Kandel, E. R., & Grant, S. G. (1991). Long-term potentiation in the 
hippocampus is blocked by tyrosine kinase inhibitors. Nature, 353(6344), 558-
560.  
 
140. Olanow, C. W., Perl, D. P., DeMartino, G. N., & McNaught, K. S. (2004). Lewy-
body formation is an aggresome-related process: A hypothesis. Lancet Neurology, 
3(8), 496-503.  
 
141. Ornstein, T. J., Iddon, J. L., Baldacchino, A. M., Sahakian, B. J., London, M., 
Everitt, B. J. (2000). Profiles of cognitive dysfunction in chronic amphetamine 
and heroin abusers. Neuropsychopharmacology : Official Publication of the 
American College of Neuropsychopharmacology, 23(2), 113-126.  
 
142. Ortiz, O., Delgado-Garcia, J. M., Espadas, I., Bahi, A., Trullas, R., Dreyer, J. L. 
(2010). Associative learning and CA3-CA1 synaptic plasticity are impaired in 
D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
30(37), 12288-12300.  
 
143. Osaka, M., Otsuka, Y., Osaka, N., Barker, G. R., & Warburton, E. C. (2011). 
Verbal to visual code switching improves working memory in older adults: An 
fMRI study; when is the hippocampus involved in recognition memory? The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 6; 
31(29), 24; 10721-10731.  
76 
 
144. Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. 
(2002). A role for alpha-synuclein in the regulation of dopamine biosynthesis. The 
Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 
22(8), 3090-3099.  
 
145. Petersen, K., Olesen, O. F., & Mikkelsen, J. D. (1999). Developmental 
expression of alpha-synuclein in rat hippocampus and cerebral cortex. 
Neuroscience, 91(2), 651-659.  
 
146. Pittenger, C., Fasano, S., Mazzocchi-Jones, D., Dunnett, S. B., Kandel, E. R., & 
Brambilla, R. (2006). Impaired bidirectional synaptic plasticity and procedural 
memory formation in striatum-specific cAMP response element-binding protein-
deficient mice. The Journal of Neuroscience: The Official Journal of the Society 
for Neuroscience, 26(10), 2808-2813.  
 
147. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A. 
(1997). Mutation in the alpha-synuclein gene identified in families with 
parkinson's disease. Science (New York, N.Y.), 276(5321), 2045-2047.  
 
148. Quinton, M. S., & Yamamoto, B. K. (2006). Causes and consequences of 
methamphetamine and MDMA toxicity. The AAPS Journal, 8(2), E337-47.  
 
149. Rawson, R. A., Gonzales, R., & Brethen, P. (2002). Treatment of 
methamphetamine use disorders: An update. Journal of Substance Abuse 
Treatment, 23(2), 145-150.  
 
150. Raymond, C. R. (2007). LTP forms 1, 2 and 3: Different mechanisms for the 
"long" in long-term potentiation. Trends in Neurosciences, 30(4), 167-175. 
  
151. Reichel, C. M., Schwendt, M., McGinty, J. F., Olive, M. F., & See, R. E. (2011). 
Loss of object recognition memory produced by extended access to 
methamphetamine self-administration is reversed by positive allosteric 
modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology: 
Official Publication of the American College of Neuropsychopharmacology, 
36(4), 782-792.  
 
152. Rendell, P. G., Mazur, M., & Henry, J. D. (2009). Prospective memory 
impairment in former users of methamphetamine. Psychopharmacology, 203(3), 
609-616.  
 
153. Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. 
(1982). Dopamine nerve terminal degeneration produced by high doses of 
methylamphetamine in the rat brain. Brain Research, 235(1), 93-103.  
 
154. Salthouse, T. A. (1996). The processing-speed theory of adult age differences in 
cognition. Psychological Review, 103(3), 403-428.  
77 
 
155. Sanderson, T. M., Cotel, M. C., O'Neill, M. J., Tricklebank, M. D., Collingridge, 
G. L., & Sher, E. (2011). Alterations in hippocampal excitability, synaptic 
transmission and synaptic plasticity in a neurodevelopmental model of 
schizophrenia. Neuropharmacology, 62(3):1349-58 
 
156. Saunders, R. C., Murray, E. A., & Mishkin, M. (1984). Further evidence that 
amygdala and hippocampus contribute equally to recognition memory. 
Neuropsychologia, 22(6), 785-796.  
 
157. Schepers, R. J., Oyler, J. M., Joseph, R. E.,Jr, Cone, E. J., Moolchan, E. T., & 
Huestis, M. A. (2003). Methamphetamine and amphetamine pharmacokinetics in 
oral fluid and plasma after controlled oral methamphetamine administration to 
human volunteers. Clinical Chemistry, 49(1), 121-132.  
 
158. Schulz-Schaeffer, W. J. (2010). The synaptic pathology of alpha-synuclein 
aggregation in dementia with lewy bodies, parkinson's disease and parkinson's 
disease dementia. Acta Neuropathologica, 120(2), 131-143.  
 
159. Segal, D. S., Kuczenski, R., O'Neil, M. L., Melega, W. P., & Cho, A. K. (2003). 
Escalating dose methamphetamine pretreatment alters the behavioral and 
neurochemical profiles associated with exposure to a high-dose methamphetamine 
binge. Neuropsychopharmacology : Official Publication of the American College 
of Neuropsychopharmacology, 28(10), 1730-1740.  
 
160. Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K. (2003). 
Association of dopamine transporter loss in the orbitofrontal and dorsolateral 
prefrontal cortices with methamphetamine-related psychiatric symptoms. The 
American Journal of Psychiatry, 160(9), 1699-1701.  
 
161. Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M. 
(2006). Brain serotonin transporter density and aggression in abstinent 
methamphetamine abusers. Archives of General Psychiatry, 63(1), 90-100.  
162. Shapiro, M. (2001). Plasticity, hippocampal place cells, and cognitive maps. 
Archives of Neurology, 58(6), 874-881.  
 
163. Sharma, H. S., & Kiyatkin, E. A. (2009). Rapid morphological brain 
abnormalities during acute methamphetamine intoxication in the rat: An 
experimental study using light and electron microscopy. Journal of Chemical 
Neuroanatomy, 37(1), 18-32. 
 
164. Shaywitz, A. J., & Greenberg, M. E. (1999). CREB: A stimulus-induced 
transcription factor activated by a diverse array of extracellular signals. Annual 
Review of Biochemistry, 68, 821-861.  
 
165. Sidhu, A., Wersinger, C., & Vernier, P. (2004). Does alpha-synuclein modulate 
dopaminergic synaptic content and tone at the synapse? FASEB Journal : Official 
78 
 
Publication of the Federation of American Societies for Experimental Biology, 
18(6), 637-647.  
 
166. Siegelbaum, S. A., & Kandel, E. R. (1991). Learning-related synaptic plasticity: 
LTP and LTD. Current Opinion in Neurobiology, 1(1), 113-120.  
 
167. Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004). The effect of 
relapse on cognition in abstinent methamphetamine abusers. Journal of Substance 
Abuse Treatment, 27(1), 59-66.  
 
168. Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. 
(2002). Cognitive performance of current methamphetamine and cocaine abusers. 
Journal of Addictive Diseases, 21(1), 61-74.  
 
169. Smith, E. E., & Grossman, M. (2008). Multiple systems of category learning. 
Neuroscience and Biobehavioral Reviews, 32(2), 249-264.  
 
170. Spillantini, M. G., Divane, A., & Goedert, M. (1995). Assignment of human 
alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 
and 5q35. Genomics, 27(2), 379-381.  
 
171. Squire, L. R. (2009). The legacy of patient H.M. for neuroscience. Neuron, 
61(1), 6-9.  
 
172. Squire, L. R., Wixted, J. T., & Clark, R. E. (2007). Recognition memory and the 
medial temporal lobe: A new perspective. Nature Reviews.Neuroscience, 8(11), 
872-883.  
 
173. Squire, L. R., & Zola, S. M. (1996). Structure and function of declarative and 
nondeclarative memory systems. Proceedings of the National Academy of 
Sciences of the United States of America, 93(24), 13515-13522.  
 
174. Squire, L. R., & Zola-Morgan, S. (1991). The medial temporal lobe memory 
system. Science (New York, N.Y.), 253(5026), 1380-1386.  
 
175. Stephan, A., Davis, S., Salin, H., Dumas, S., Mallet, J., & Laroche, S. (2002). 
Age-dependent differential regulation of genes encoding APP and alpha-synuclein 
in hippocampal synaptic plasticity. Hippocampus, 12(1), 55-62.  
 
176. Swant, J., Chirwa, S., Stanwood, G., & Khoshbouei, H. (2010). 
Methamphetamine reduces LTP and increases baseline synaptic transmission in 
the CA1 region of mouse hippocampus. PloS One, 5(6), e11382. 
  
177. Theysohn, J. M., Kraff, O., Maderwald, S., Schlamann, M. U., de Greiff, A., 
Forsting, M. (2009). The human hippocampus at 7 T--in vivo MRI. Hippocampus, 
19(1), 1-7.  
79 
 
178. Thompson, C. L., Pathak, S. D., Jeromin, A., Ng, L. L., MacPherson, C. R., 
Mortrud, M. T. (2008). Genomic anatomy of the hippocampus. Neuron, 60(6), 
1010-1021.  
 
179. Tomsic, D., de Astrada, M. B., Sztarker, J., & Maldonado, H. (2009). Behavioral 
and neuronal attributes of short- and long-term habituation in the crab 
chasmagnathus. Neurobiology of Learning and Memory, 92(2), 176-182.  
 
180. Tsigelny, I. F., Crews, L., Desplats, P., Shaked, G. M., Sharikov, Y., Mizuno, H. 
(2008). Mechanisms of hybrid oligomer formation in the pathogenesis of 
combined alzheimer's and parkinson's diseases. PloS One, 3(9), e3135. 
  
181. Tulving, E., & Markowitsch, H. J. (1997). Memory beyond the hippocampus. 
Current Opinion in Neurobiology, 7(2), 209-216.  
 
182. Uversky, V. N., Li, J., & Fink, A. L. (2001). Evidence for a partially folded 
intermediate in alpha-synuclein fibril formation. The Journal of Biological 
Chemistry, 276(14), 10737-10744. 
 
183. Uversky, V. N., Winter, S., Galzitskaya, O. V., Kittler, L., & Lober, G. (1998). 
Hyperphosphorylation induces structural modification of tau-protein. FEBS 
Letters, 439(1-2), 21-25.  
 
184. Verdejo-Garcia, A., Bechara, A., Recknor, E. C., & Perez-Garcia, M. (2006). 
Executive dysfunction in substance dependent individuals during drug use and 
abstinence: An examination of the behavioral, cognitive and emotional correlates 
of addiction. Journal of the International Neuropsychological Society : JINS, 
12(3), 405-415.  
 
185. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M. 
(2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: 
Association with metabolism in the orbitofrontal cortex. The American Journal of 
Psychiatry, 158(12), 2015-2021.  
 
186. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M., 
Franceschi, D., et al. (2001). Association of dopamine transporter reduction with 
psychomotor impairment in methamphetamine abusers. The American Journal of 
Psychiatry, 158(3), 377-382.  
 
187. Wagner, A. D., Maril, A., & Schacter, D. L. (2000). Interactions between forms 
of memory: When priming hinders new episodic learning. Journal of Cognitive 
Neuroscience, 12 Suppl 2, 52-60.  
 
188. Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., & 
Westley, J. (1980). Long-lasting depletions of striatal dopamine and loss of 
80 
 
dopamine uptake sites following repeated administration of methamphetamine. 
Brain Research, 181(1), 151-160.  
 
189. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T.,Jr. 
(1996). NACP, a protein implicated in alzheimer's disease and learning, is 
natively unfolded. Biochemistry, 35(43), 13709-13715.  
 
190. Willingham, D. B. (1998). A neuropsychological theory of motor skill learning. 
Psychological Review, 105(3), 558-584.  
 
191. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., 
Anthony, R. M., et al. (2003). Striatal dopamine nerve terminal markers in 
human, chronic methamphetamine users; escalating dose methamphetamine 
pretreatment alters the behavioral and neurochemical profiles associated with 
exposure to a high-dose methamphetamine binge. Neuropsychopharmacology: 
Official Publication of the American College of Neuropsychopharmacology, 2; 
28(6; 10), 699; 1730-703; 1740.  
 
192. Winslow, B. T., Voorhees, K. I., & Pehl, K. A. (2007). Methamphetamine abuse. 
American Family Physician, 76(8), 1169-1174.  
 
193. Winters, B. D., Saksida, L. M., & Bussey, T. J. (2008). Object recognition 
memory: Neurobiological mechanisms of encoding, consolidation and retrieval. 
Neuroscience and Biobehavioral Reviews, 32(5), 1055-1070.  
 
194. Wise, R. A., & Bozarth, M. A. (1985). Brain mechanisms of drug reward and 
euphoria. Psychiatric Medicine, 3(4), 445-460.  
 
195. Witter, M. P. (2007). The perforant path: Projections from the entorhinal cortex 
to the dentate gyrus. Progress in Brain Research, 163, 43-61. 
 
196. Witter, M. P., Griffioen, A. W., Jorritsma-Byham, B., & Krijnen, J. L. (1988). 
Entorhinal projections to the hippocampal CA1 region in the rat: An 
underestimated pathway. Neuroscience Letters, 85(2), 193-198. 
 
197. Wixted, J. T., & Squire, L. R. (2010). The role of the human hippocampus in 
familiarity-based and recollection-based recognition memory. Behavioural Brain 
Research, 215(2), 197-208.  
 
198. Wolfman, C., Fin, C., Dias, M., Bianchin, M., Da Silva, R. C., Schmitz, P. K. 
(1994). Intrahippocampal or intraamygdala infusion of KN62, a specific inhibitor 
of calcium/calmodulin-dependent protein kinase II, causes retrograde amnesia in 
the rat. Behavioral and Neural Biology, 61(3), 203-205.  
 
81 
 
199. Woods, S. P., Rippeth, J. D., Conover, E., Gongvatana, A., Gonzalez, R., Carey, 
C. L. (2005). Deficient strategic control of verbal encoding and retrieval in 
individuals with methamphetamine dependence. Neuropsychology, 19(1), 35-43.  
 
200. Worley, P. F., Bhat, R. V., Baraban, J. M., Erickson, C. A., McNaughton, B. L., 
& Barnes, C. A. (1993). Thresholds for synaptic activation of transcription factors 
in hippocampus: Correlation with long-term enhancement. The Journal of 
Neuroscience: The Official Journal of the Society for Neuroscience, 13(11), 4776-
4786.  
 
201. Wu, G. Y., Deisseroth, K., & Tsien, R. W. (2001). Activity-dependent CREB 
phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and 
a slow, less sensitive mitogen-activated protein kinase pathway. Proceedings of 
the National Academy of Sciences of the United States of America, 98(5), 2808-
2813. 
 
202. Yoshimoto, M., Iwai, A., Kang, D., Otero, D. A., Xia, Y., & Saitoh, T. (1995). 
NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) 
component of alzheimer disease amyloid, binds A beta and stimulates A beta 
aggregation. Proceedings of the National Academy of Sciences of the United 
States of America, 92(20), 9141-9145. 
  
203. Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, 
D. (2004). Psychiatric symptoms in methamphetamine users. The American 
Journal on Addictions / American Academy of Psychiatrists in Alcoholism and 
Addictions, 13(2), 181-190. 
